{
  "meta": {
    "title": "00357_Late_Night_Pyq_Inicet_Mixed_Bag-1",
    "url": "https://brainandscalpel.vercel.app/00357-late-night-pyq-inicet-mixed-bag-1-f7bb1feb.html",
    "scrapedAt": "2025-11-29T18:10:36.201Z"
  },
  "questions": [
    {
      "id": 13792,
      "choices": [
        {
          "id": 55129,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Thoracic duct</span></p>"
        },
        {
          "id": 55130,
          "text": "<p><span style=\"font-size:9pt;\">﻿﻿﻿</span><span style=\"font-size:12.0pt;\">Right atrium</span></p>"
        },
        {
          "id": 55131,
          "text": "<p><span style=\"font-size:12.0pt;\">Inferomedial bronchopulmonary segments</span></p>"
        },
        {
          "id": 55132,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Hilum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">The region marked corresponds to the surface marking for which of the following structures:(AIIMS MAY 2019)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/26/whatsapp-image-2023-06-12-at-1901222.jpg\" alt=\"\" width=\"300\" height=\"330\"></p>",
      "unique_key": "Q9613012",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682124,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B. Right atrium</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The region marked corresponds to the surface marking for the right atrium.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">This image shows the mid-clavicular line, xiphoid process, and costal margin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The examiner marks a laterally convex line that runs from the third costal cartilage, which is located about three spaces below the second costal cartilage (as shown by the sternal angle), to the sixth costal cartilage. The distance between this line and the sternal margin is around 1.2 cm. This imply that the area designated matches the right atrium's surface marking.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">An average adult's projected cardiac borders onto the front chest wall form a trapezium shape. The percussion approach can be used to map this out by checking for cardiac dullness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.&nbsp;Thoracic duct:</strong> The thoracic duct typically ascends in the posterior mediastinum and does not correspond to the surface marking in the image which is more anterior and lateral.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.&nbsp;Inferomedial bronchopulmonary segments:</strong> These segments are located more inferiorly in the lung fields and do not correspond to the area marked which is on the chest wall at the level of the heart.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.&nbsp;Hilum:</strong> The hilum of the lung, where structures enter and exit the lung, is located more laterally than the area marked. It does not align with the vertical placement of the right atrium.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The varying heart borders and the corresponding surface markings are as follows:</span></p><p>&nbsp;</p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">﻿﻿Upper border: Slopes gently from the second left costal cartilage to the third right costal cartilage. It corresponds to the left atrium.</span></li><li><span style=\"font-size:12pt;\">﻿﻿Right border: Convex to the right and runs from the third to the sixth right costal cartilages, 1-2 cm lateral to the sternal edge. It corresponds to the right atrium.</span></li><li><span style=\"font-size:12pt;\">﻿﻿Inferior border or acute border: Runs leftwards from the 6th right costal cartilage to the cardiac apex which is located approximately</span></li><li><span style=\"font-size:12pt;\">9 cm lateral to the midline, often in the left 5th intercostal space or level with the 5th or 6th rib. It corresponds to the right ventricle.</span></li><li><span style=\"font-size:12.0pt;\">﻿﻿Left border or obtuse border: Convex laterally on the left. It extends superomedially from the cardiac apex to meet the second left costal cartilage about 1 cm from the left sternal edge. It corresponds to the left ventricle.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/picture3.jpg\" alt=\"\" width=\"500\" height=\"650\"></p>",
      "correct_choice_id": 55130,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24729,
      "choices": [
        {
          "id": 98877,
          "text": "<p><span style=\"font-size:12.0pt;\">Target cell</span></p>"
        },
        {
          "id": 98878,
          "text": "<p><span style=\"font-size:12.0pt;\">Hairy cell</span></p>"
        },
        {
          "id": 98879,
          "text": "<p><span style=\"font-size:12.0pt;\">Gaucher cell</span></p>"
        },
        {
          "id": 98880,
          "text": "<p><span style=\"font-size:12.0pt;\">Sickle cell</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Below is an electron microscopy depiction of a cellular structure. Determine the type of cell being depicted:</span>&nbsp;<span style=\"font-size:11.0pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2023)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/11/whatsapp-image-2023-07-04-at-125679.jpg\" alt=\"\" width=\"300\" height=\"267\"></span></p>",
      "unique_key": "Q8434271",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682098,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Hairy cell</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hairy cells are seen in Hairy cell leukemia. It is a B-cell tumor. Peripheral smear shows pancytopenia; hairy cells. Flow cytometry shows CD11/25/103 + cells. Annexin –A is the best marker.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Target cell</strong>: Target cell can be seen in&nbsp;thalassemia, hepatic disease with jaundice, hemoglobin C disorders, and the postsplenectomy state.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/11/whatsapp-image-2023-07-04-at-125680.jpg\" alt=\"\" width=\"300\" height=\"214\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Gaucher cell</strong>: Gaucher cell is found in Gaucher’s disease which occurs due to absence of beta glucocerebrosidase enzyme..</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/11/whatsapp-image-2023-07-04-at-125681.jpg\" alt=\"\" width=\"300\" height=\"221\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Sickle cells</strong>: Sickle cells are seen in sickle cell anemia. HbS has altered solubility and high chance of polymer formation especially with dehydration or hypoxemia causing alteration in shape. On rehydration, it is reversible.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/11/whatsapp-image-2023-07-04-at-125682.jpg\" alt=\"\" width=\"300\" height=\"236\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hairy cells, with their distinctive cytoplasmic projections, are a hallmark of Hairy Cell Leukemia, a chronic B-cell malignancy.</span></p>",
      "correct_choice_id": 98878,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9934,
      "choices": [
        {
          "id": 39702,
          "text": "<p><span style=\"font-size:12pt;\">Alopecia areata</span></p>"
        },
        {
          "id": 39703,
          "text": "<p><span style=\"font-size:12pt;\">Telogen effluvium</span></p>"
        },
        {
          "id": 39704,
          "text": "<p><span style=\"font-size:12pt;\">Tinea infection</span></p>"
        },
        {
          "id": 39705,
          "text": "<p><span style=\"font-size:12pt;\">Trichotillomania</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The diagnosis for a 23-year-old patient presenting with non-scarring alopecia in the vertex region of the head, and exhibiting histological findings of hair loss with haemorrhage into the follicular areas and mild perinuclear lymphocytic infiltrate, is what?&nbsp;</span><br><span style=\"font-size:12.0pt;\">(</span>AIIMS Nov 2017)</p>",
      "unique_key": "Q7240545",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682107,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Trichotillomania</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">From the given clinical features &amp; histopathological features, diagnosis is <strong>Trichotillomania (TTM) / Trichotillosis / Hair pulling disorder.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Clinical features suggestive of Trichotillomania in the clinical vignette:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The clinical history revealing <strong>non scarring alopecia</strong> in the vertex region (<strong>Hair pulling and plucking is commonest from the scalp</strong>)</span></li><li><span style=\"font-size:12pt;\"><strong>No&nbsp;</strong>signs of <strong>inflammation</strong></span></li><li><span style=\"font-size:12pt;\">Perifollicular <strong>hemorrhage</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Diagnostic criteria for TTM include:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Recurrent pulling&nbsp;</strong>out of one’s own hair resulting in <strong>non-scarring hair loss</strong>.</span></li><li><span style=\"font-size:12pt;\">An increasing sense of <strong>tension</strong> immediately <strong>before pulling out</strong> the hair or when <strong>attempting to resist</strong> the behaviour.</span></li><li><span style=\"font-size:12pt;\"><strong>Pleasure, gratification, or relief</strong> when pulling out the hair.</span></li><li><span style=\"font-size:12pt;\">The disturbance is <strong>not</strong> better <strong>accounted</strong> for by <strong>another mental disorder</strong>.</span></li><li><span style=\"font-size:12pt;\">The disturbance provokes <strong>clinically marked distress</strong> and/or impairment in <strong>occupational, social</strong>, or other areas of <strong>functioning.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Histopathology: No / Minimal inflammation</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Peribulbar hemorrhage&nbsp;</strong>- due to <strong>trauma</strong> from <strong>plucking</strong> of hair.</span></li><li><span style=\"font-size:12pt;\">intraepithelial and perifollicular hemorrhage and intrafollicular pigment casts.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Alopecia areata:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">While it is characterized by <strong>non-scarring alopecia</strong> and can have l<strong>ymphocytic</strong> infiltrate around the hair follicles, the <strong>hemorrhage</strong> is <strong>not a typical feature.</strong></span></li><li><span style=\"font-size:12pt;\">Generally presents as <strong>well-defined patches of hair loss</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Telogen effluvium:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">It manifests as a <strong>diffuse or generalized </strong>hair shedding from the <strong>entire scalp </strong>rather than localized patches.</span></li><li><span style=\"font-size:12pt;\">It's commonly due to <strong>stress</strong>, certain <strong>medications</strong>, or <strong>illnesses</strong>.</span></li><li><span style=\"font-size:12pt;\">Histopathology would not typically show hemorrhage or the specific perinuclear infiltrate described.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Tinea infection:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Tinea capitis is a fungal infection of the scalp.</span></li><li><span style=\"font-size:12pt;\">It usually presents with <strong>scaling</strong> and possibly <strong>broken-off hairs.</strong></span></li><li><span style=\"font-size:12pt;\">Histological examination would show evidence of fungal elements (<strong>hyphae and spores</strong>) rather than hemorrhage or lymphocytic infiltrate.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In a young patient with <strong>non-scarring alopecia </strong>in the <strong>vertex</strong> region and histological findings of hair loss with <strong>follicular hemorrhage </strong>and <strong>mild lymphocytic </strong>infiltrate, the diagnosis is likely <strong>Trichotillomania</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/27/screenshot-2023-11-27-181350.jpg\" alt=\"\" width=\"1000\" height=\"590\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref - Rooks textbook of dermatology - 9<sup>th</sup> Edition Chapter 86 &amp; 89, page nos 86.17 &amp; 89.31</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Fitzpatrick’s dermatology 9<sup>th</sup> edition page no: 1695</strong></span></p>",
      "correct_choice_id": 39705,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13945,
      "choices": [
        {
          "id": 55741,
          "text": "<p><span style=\"font-size:12.0pt;\">Strap his thorax, abdomen and lower limbs on a stretcher</span></p>"
        },
        {
          "id": 55742,
          "text": "<p><span style=\"font-size:12.0pt;\">Apply a cervical collar</span></p>"
        },
        {
          "id": 55743,
          "text": "<p><span style=\"font-size:12.0pt;\">Put patient on lateral position and shift him immediately</span></p>"
        },
        {
          "id": 55744,
          "text": "<p><span style=\"font-size:12.0pt;\">Roll the patient and put on a hard board</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are done to transport a polytrauma patient who is conscious except? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q9309920",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682134,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Put patient on lateral position and shift him immediately</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This option is not a standard practice when transporting conscious polytrauma patients. Shifting a conscious patient to a lateral position and immediately moving them can risk further injury and discomfort.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Strap his thorax, abdomen, and lower limbs on a stretcher:&nbsp;</strong>This is a common and necessary practice when transporting a conscious polytrauma patient. It helps secure the patient to the stretcher to prevent movement and further injury during transport.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Apply a cervical collar:&nbsp;</strong>This is done to immobilize the cervical spine, till a cervical injury is ruled out.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Roll the patient and put on a hardboard:&nbsp;</strong>Rolling a conscious polytrauma patient and placing them on a hardboard (spinal board) can be a part of the standard protocol for immobilizing the spine and minimizing movement during transport. This is done to prevent potential spinal cord injuries.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Patients with polytrauma are shifted in supine or prone position (not in lateral position) by laying them over a firm surface, in order to restrict the spinal movement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">As per ATLS guidelines, in patients with trauma, airway management is first done along with cervical spine stabilization. All trauma patients unless proven otherwise are considered to have an injured vertebral column.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient is placed supine on a firm surface without rotating or bending the spinal column and a rigid cervical collar (Philadelphia collar) is applied.</span></p>",
      "correct_choice_id": 55743,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6705,
      "choices": [
        {
          "id": 26789,
          "text": "<p><span style=\"font-size:12.0pt;\">Triad of confusion, ophthalmoplegia, and ataxia</span></p>"
        },
        {
          "id": 26790,
          "text": "<p><span style=\"font-size:12.0pt;\">Loss of long-term memory but intact personality</span></p>"
        },
        {
          "id": 26791,
          "text": "<p><span style=\"font-size:12.0pt;\">Anterograde amnesia with loss of recent memory</span></p>"
        },
        {
          "id": 26792,
          "text": "<p><span style=\"font-size:12.0pt;\">Loss of implicit memory and immediate recall</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is true statement about Korsakoff syndrome? (</span>INICET Nov 2021)</p>",
      "unique_key": "Q3467314",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682128,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Anterograde amnesia with loss of recent memory</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Korsakoff syndrome is a chronic memory disorder caused by severe deficiency of thiamine (vitamin B1). The most common cause is alcohol misuse, but other conditions that affect nutrition can also lead to Korsakoff syndrome. Its main feature is anterograde amnesia with loss of recent memory i.e., patients with Korsakoff syndrome can't acquire new information or recall recent events, but long-term memories from before the onset of the illness remain intact.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Triad of confusion, ophthalmoplegia, and ataxia: </strong>Refers to Wernicke's encephalopathy, which often precedes Korsakoff syndrome and presents with a triad of confusion, ophthalmoplegia, and ataxia. If left untreated, Wernicke's can progress to Korsakoff syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Loss of long-term memory but intact personality:</strong> While long-term memories may be affected in Korsakoff syndrome, it is not a characteristic feature. Personality changes, apathy, and lack of insight can be seen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Loss of implicit memory and immediate recall:</strong> Korsakoff syndrome predominantly affects explicit memory (conscious recall of facts and events), not implicit memory (unconscious memory like skills).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Korsakoff syndrome is a chronic memory disorder caused by thiamine (vitamin B1) deficiency. It is primarily associated with chronic alcohol misuse. It is characterized by anterograde amnesia (difficulty forming new memories) and often retrograde amnesia (loss of past memories). Confabulation is common, where patients fill memory gaps with fabricated information. Treatment involves thiamine replacement and abstaining from alcohol. It often follows or coexists with Wernicke's encephalopathy, which is an acute syndrome requiring immediate thiamine treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: A Short Textbook of Psychiatry, 7th edition, Page No 38-40.</strong></span></p>",
      "correct_choice_id": 26791,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9781,
      "choices": [
        {
          "id": 39091,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Allergic</span></span></span></p>"
        },
        {
          "id": 39092,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Transfusion related circulatory overload</span></span></span></p>"
        },
        {
          "id": 39093,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Transfusion-related acute lung injury</span></span></span></p>"
        },
        {
          "id": 39094,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Febrile non-hemolytic transfusion reaction</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A CKD patient had to undergo dialysis and his Hb was 5.2gm/dL. So two blood transfusions were to be given. The first bag was completed in 2 hours. The second was started and in the midway, he developed shortness of breath and hypertension. Vitals Were BP - 180/120 mmHg and pulse rate - 110 min. What is the cause?&nbsp;</span></span>(AIIMS MAY 2019)</p>",
      "unique_key": "Q7606296",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682096,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Transfusion related circulatory overload</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The given clinical scenario is suggestive of transfusion-associated circulatory overload (TACO).</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Transfusion associated circulatory overload includes any four of the following occurring within 6 h of a blood transfusion - acute respiratory distress, tachycardia, increased blood pressure (BP), acute or worsening pulmonary edema and evidence of a positive fluid balance.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">TACO may occur due to rapid or excess transfusion of red cell preparations or plasma products.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prevented is by slow transfusion at the rate of 1 to 2 ml of blood/kg of body weight per hour. Diuretics are also used if necessary.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Allergic</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Allergic reactions to blood transfusions usually present with urticaria (hives), pruritus (itching), and sometimes anaphylaxis, but do not typically cause the significant hypertension and tachycardia seen in this case.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Transfusion-related acute lung injury (TRALI)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: TRALI is characterized by acute onset of non-cardiogenic pulmonary edema, leading to respiratory distress and hypoxemia during or within 6 hours of transfusion. However, TRALI typically presents with hypotension or normal blood pressure, not the significant hypertension seen here.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Febrile non-hemolytic transfusion reaction</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This reaction typically presents with fever, chills, and rigors, but does not cause the hemodynamic instability (hypertension and tachycardia) seen in TACO.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Transfusion-related circulatory overload (TACO) is a potential complication of blood transfusion, particularly in patients with predisposing conditions like CKD. It presents with respiratory distress, hypertension, and tachycardia and can be prevented by careful monitoring and slow transfusion.</span></span></span></p>",
      "correct_choice_id": 39092,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10096,
      "choices": [
        {
          "id": 40350,
          "text": "<p><span style=\"font-size:12.0pt;\">Melasma</span></p>"
        },
        {
          "id": 40351,
          "text": "<p><span style=\"font-size:12.0pt;\">Fixed drug eruption</span></p>"
        },
        {
          "id": 40352,
          "text": "<p><span style=\"font-size:12.0pt;\">Dengue</span></p>"
        },
        {
          "id": 40353,
          "text": "<p><span style=\"font-size:12.0pt;\">Chikungunya</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:13.0pt;\">A 38-year-old woman who presented with complaints of fever and joint pain develops the following lesion on her nose after a few days of taking NSAIDs. What is your diagnosis?</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13541_FPCfPCR.jpg\" alt=\"\" width=\"400\" height=\"155\"></span></p><p>&nbsp;</p>",
      "unique_key": "Q6736475",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682102,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>D) Chikungunya</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The patient's medical history is indicative of a potential diagnosis of <strong>Chikungunya (CKG)</strong> infection.</span></li><li><span style=\"font-size:12.0pt;\">Chikungunya is a <strong>mosquito-borne viral</strong> illness presenting with <strong>fever, joint pain,</strong> and potential rash.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-135455.png\" alt=\"\" width=\"300\" height=\"223\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Fig: Nose pigmentation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>IMAGE DEPICTING CHIK SIGN</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">It can cause skin <strong>hyperpigmentation</strong>, especially on the <strong>nose and cheeks</strong>, known as the <strong>\"Chik sign.\"</strong></span></li><li><span style=\"font-size:12.0pt;\">The \"Chik sign\" is <strong>distinctive to Chikungunya</strong> and is not usually seen with other viral infections.</span></li><li><span style=\"font-size:12.0pt;\">The <strong>nose</strong> pigmentation may last <strong>three to six months</strong> post-infection, aiding in <strong>clinical and retrospective diagnosis</strong>.</span></li><li><span style=\"font-size:12.0pt;\">This pigmentation pattern serves as a <strong>clinical marker</strong> for Chikungunya infection.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Melasma</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Typically presents as <strong>symmetric brown</strong> patches on the face, especially the <strong>cheeks, bridge of the nose, forehead, chin, and above the upper lip</strong> as shown in the image below.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-135612.png\" alt=\"\" width=\"300\" height=\"204\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It is often triggered by <strong>sun exposure</strong> or <strong>hormonal changes</strong>, such as <strong>pregnancy</strong> or use of <strong>oral contraceptives</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Fixed drug eruption (FDE)</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">It is a type of <strong>allergic</strong> reaction to <strong>medications</strong>. It presents as well-demarcated, round, or oval patches of <strong>redness a</strong>nd s<strong>welling</strong> that can later become <strong>brown</strong>.</span></li><li><span style=\"font-size:12.0pt;\">However, FDEs are typically r<strong>ecurrent</strong> in the <strong>same location</strong> when the offending <strong>drug is taken again</strong>, and the presentation isn't specifically associated with the symptoms described.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Dengue</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">While dengue fever is also a <strong>mosquito-borne</strong> viral infection leading to symptoms like <strong>fever, headache, and joint pains</strong>, it does not typically result in brownish pigmentation on the nose.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the context of <strong>fever, body ache, and joint pain</strong>, followed by the development of <strong>brownish pigmentation</strong> on the nose, <strong>Chikungunya</strong> is the probable diagnosis, as it can present with persistent <strong>joint pain</strong> and <strong>hyperpigmentation,</strong> particularly in regions where the virus is <strong>endemic.</strong></span></p>",
      "correct_choice_id": 40353,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6155,
      "choices": [
        {
          "id": 24589,
          "text": "<p><span style=\"font-size:12.0pt;\">Mania</span></p>"
        },
        {
          "id": 24590,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypomania</span></p>"
        },
        {
          "id": 24591,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyclothymia</span></p>"
        },
        {
          "id": 24592,
          "text": "<p><span style=\"font-size:12.0pt;\">Schizomania</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 16-year-old girl presented with overfamiliarity, flight of ideas, elevated mood, increased sexual desire, and pseudo hallucination. What is the likely diagnosis?&nbsp;</span>(NEET PG 2021)</p>",
      "unique_key": "Q8373146",
      "question_audio": null,
      "question_video": null,
      "map_id": 32705197,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Mania</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's symptoms of overfamiliarity, flight of ideas, elevated mood, increased sexual desire, and pseudo hallucination are indicative of a manic episode. Mania is characterized by an elevated, expansive, or irritable mood, lasting at least one week, associated with increased energy or activity, and causing significant impairment in social or occupational functioning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hypomania:</strong> Similar to mania but the symptoms are milder, last for at least 4 days, and don't significantly impair social or occupational functioning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Cyclothymia:</strong> A mood disorder characterized by periods of hypomanic symptoms and periods of depressive symptoms that don't meet the full criteria for a manic or major depressive episode.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Schizomania:</strong> This term is not standard in psychiatric diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mania is characterized by an elevated, expansive, or irritable mood, lasting at least one week, associated with increased energy or activity, and causing significant impairment in social or occupational functioning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Kaplan and Sadock’s Synopsis of Psychiatry, 12th edition, Page No 365</strong></span></p>",
      "correct_choice_id": 24589,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56093,
      "choices": [
        {
          "id": 223797,
          "text": "<p><span style=\"font-size:12.0pt;\">Selective mutism</span></p>"
        },
        {
          "id": 223798,
          "text": "<p><span style=\"font-size:12.0pt;\">Conduct disorder</span></p>"
        },
        {
          "id": 223799,
          "text": "<p><span style=\"font-size:12.0pt;\">Binge eating disorder</span></p>"
        },
        {
          "id": 223800,
          "text": "<p><span style=\"font-size:12.0pt;\">Separation anxiety disorder</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The persistence of ADHD in childhood increases the risk of development of which of the following in adolescence? (NEET PG 2024)</span></p>",
      "unique_key": "Q9487814",
      "question_audio": null,
      "question_video": null,
      "map_id": 32705191,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Conduct disorder</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Children with Attention-Deficit/Hyperactivity Disorder (ADHD) are at an increased risk of developing conduct disorder during adolescence. ADHD is characterized by impulsivity, hyperactivity, and inattention, which can lead to difficulty in following rules, controlling behavior, and maintaining social norms. When these symptoms persist into adolescence, they can manifest as more serious behavioral problems, such as conduct disorder, characterized by aggressive, antisocial, or defiant behaviors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Conduct disorder is a common progression from ADHD because the underlying impulsivity and lack of self-control associated with ADHD often worsen over time, particularly when untreated. This progression underscores the importance of early intervention in managing ADHD symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Note - Children with ADHD are at risk of developing depression, antisocial personality disorder, substance use disorder, and conduct disorder <strong>as adults</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Selective mutism:</strong> This disorder involves a consistent failure to speak in specific social situations despite speaking in other situations, and it is more associated with anxiety disorders rather than ADHD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Binge eating disorder:</strong> This condition involves recurrent episodes of eating large quantities of food, often quickly and to the point of discomfort. It is associated more with emotional regulation issues rather than impulsivity or behavioral problems typical of ADHD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Separation anxiety disorder:</strong> This disorder is characterized by excessive fear or anxiety about separation from attachment figures. It is more commonly associated with anxiety disorders and does not have a direct link to ADHD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The persistence of ADHD in childhood significantly increases the risk of developing conduct disorder during adolescence, highlighting the need for early and effective management of ADHD symptoms.</span></p>",
      "correct_choice_id": 223798,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56097,
      "choices": [
        {
          "id": 223813,
          "text": "<p><span style=\"font-size:18px;\">Cyproheptadine</span></p>"
        },
        {
          "id": 223814,
          "text": "<p><span style=\"font-size:18px;\">Lorazepam</span></p>"
        },
        {
          "id": 223815,
          "text": "<p><span style=\"font-size:18px;\">L-carnitine</span></p>"
        },
        {
          "id": 223816,
          "text": "<p><span style=\"font-size:18px;\">Leucovorin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">A 45-year-old patient with a history of depression was initially being treated with sertraline, but his symptoms were not adequately controlled. His medication regimen was changed to include an MAO inhibitor and amitriptyline. Shortly after the change in medication, the patient developed agitation, seizures, hyperreflexia, and tremors. Which of the following is the most appropriate treatment for this patient? (NEET PG 2024)</span></p>",
      "unique_key": "Q1385833",
      "question_audio": null,
      "question_video": null,
      "map_id": 32705187,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. A) Cyproheptadine</strong></span></p><p><span style=\"font-size:18px;\"><strong>&nbsp;&nbsp;</strong></span></p><p><span style=\"font-size:18px;\">The patient’s symptoms of agitation, seizures, hyperreflexia, and tremors are indicative of serotonin syndrome. Serotonin syndrome is a potentially life-threatening condition that occurs due to excessive serotonergic activity in the nervous system, usually as a result of combining medications that increase serotonin levels, such as SSRIs, MAO inhibitors, and TCAs. In this case, the combination of sertraline (an SSRI), an MAO inhibitor, and amitriptyline (a TCA) significantly increases serotonin, leading to the development of serotonin syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Symptoms of Serotonin Syndrome: (<strong>Mnemonic – RASH D</strong>)</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>R</strong>estlessness</span></li><li><span style=\"font-size:18px;\"><strong>A</strong>gitation</span></li><li><span style=\"font-size:18px;\"><strong>S</strong>eizures</span></li><li><span style=\"font-size:18px;\"><strong>H</strong>yperreflexia</span></li><li><span style=\"font-size:18px;\"><strong>D</strong>iarrhea</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">Cyproheptadine is an antihistamine with serotonin receptor antagonist properties, making it the drug of choice for treating serotonin syndrome. It works by blocking serotonin receptors, thereby reducing the excessive serotonergic activity causing the symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option. Lorazepam</strong>: Lorazepam is a benzodiazepine used to manage agitation and seizures but does not directly treat the underlying cause of serotonin syndrome. It is used as supportive therapy but is not the primary treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. L-carnitine</strong>: L-carnitine is a supplement often used in metabolic conditions and does not play a role in treating serotonin syndrome. It has no effect on serotonin levels or receptor activity.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Leucovorin</strong>: Leucovorin is a form of folic acid used as a rescue agent in methotrexate toxicity and other specific conditions. It has no role in the management of serotonin syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Serotonin syndrome can occur when serotonergic drugs are combined, such as SSRIs, MAO inhibitors, and TCAs. The treatment of choice for serotonin syndrome is Cyproheptadine, a serotonin receptor antagonist.</span></p>",
      "correct_choice_id": 223813,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23200,
      "choices": [
        {
          "id": 92764,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2</span></p>"
        },
        {
          "id": 92765,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4</span></p>"
        },
        {
          "id": 92766,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4</span></p>"
        },
        {
          "id": 92767,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following muscles form the pelvic diaphragm?(INICET MAY 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1. Iliococcygeus</span></p><p><span style=\"font-size:12.0pt;\">2. Pubococcygeus</span></p><p><span style=\"font-size:12.0pt;\">3. Obturator internus</span></p><p><span style=\"font-size:12.0pt;\">4. Deep transverse perinei</span></p><p>&nbsp;</p>",
      "unique_key": "Q6701406",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682159,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. &nbsp;1, 2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Iliococcygeus and pubococcygeus muscles are components of the pelvic diaphragm, commonly referred to as the levator ani.</span></p><p>&nbsp;</p><p><span style=\"color:#231f20;font-size:12.0pt;\">The pelvic diaphragm is a muscular partition between the true pelvis and the perineum. It is formed by the large levator ani and small coccygeus muscles of two sides and their covering fasciae.</span></p><p>&nbsp;</p><p><span style=\"color:#231f20;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/04/anotmy-12.jpg\" alt=\"\" width=\"700\" height=\"396\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Iliococcygeus</strong>: The iliococcygeus is one of the muscles that form the pelvic diaphragm. It is part of the levator ani muscle group. The levator ani consists of the iliococcygeus, pubococcygeus, and puborectalis muscles. The iliococcygeus muscle extends from the ischial spine (a bony projection in the pelvis) to the coccyx (the tailbone) and contributes to the support of the pelvic floor.</span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Pubococcygeus</strong>: The pubococcygeus muscle is another component of the levator ani muscle group and is a part of the pelvic diaphragm. It extends from the pubic bone to the coccyx and helps maintain pelvic organ support and control.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Obturator Internus</strong>: The obturator internus is not considered a part of the pelvic diaphragm. It is a separate muscle located in the pelvic region, and its primary function is to laterally rotate the thigh. While it is near the pelvic diaphragm, it does not contribute to its formation.</span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Deep Transverse Perinei</strong>: The deep transverse perineal muscles are not typically considered part of the pelvic diaphragm. These muscles are located in the perineum (the area between the anus and the genitalia) and play a role in stabilizing the perineal body and supporting the pelvic organs. They are important for urinary and fecal continence.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The pelvic diaphragm is formed by the iliococcygeus and pubococcygeus muscles (part of the levator ani muscle group). The obturator internus and deep transverse perineal muscles are nearby but are not considered part of the pelvic diaphragm itself.</span></p>",
      "correct_choice_id": 92764,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56096,
      "choices": [
        {
          "id": 223809,
          "text": "<p><span style=\"font-size:12.0pt;\">Cocaine</span></p>"
        },
        {
          "id": 223810,
          "text": "<p><span style=\"font-size:12.0pt;\">Morphine</span></p>"
        },
        {
          "id": 223811,
          "text": "<p><span style=\"font-size:12.0pt;\">Heroin</span></p>"
        },
        {
          "id": 223812,
          "text": "<p><span style=\"font-size:12.0pt;\">Chlordiazepoxide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 17-year-old girl presents to the emergency and is found to have raised blood pressure, tachycardia, diaphoresis, and mydriasis. The mother reports that she saw her consuming a substance in an unknown dose. What is the likely substance? (NEET PG 2024)</span></p>",
      "unique_key": "Q7300564",
      "question_audio": null,
      "question_video": null,
      "map_id": 32705188,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Cocaine</strong></span></p><p><span style=\"font-size:11pt;\"><strong>&nbsp;&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\">The patient presents with symptoms of sympathetic overactivity, including raised blood pressure, tachycardia, diaphoresis (excessive sweating), and mydriasis (dilated pupils). These symptoms are characteristic of stimulant intoxication, particularly with substances that increase the release of catecholamines, such as cocaine. Cocaine is a powerful central nervous system stimulant that induces a surge of dopamine, leading to intense sympathetic activation, which matches the symptoms described.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Morphine:&nbsp;</strong>Morphine is an opioid that causes <strong>respiratory and cardiovascular depression,</strong> pinpoint pupils (miosis), and reduced sympathetic activity, which is the opposite of what is observed in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;Heroin:&nbsp;</strong>Like morphine, heroin is an opioid that results in symptoms of <strong>sedation, respiratory depression, and miosis</strong>, rather than the sympathetic overdrive seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Chlordiazepoxide:&nbsp;</strong>Chlordiazepoxide is a benzodiazepine that acts as a <strong>sedative and anxiolytic</strong>. It would typically cause sedation, hypotension, and muscle relaxation, not the heightened sympathetic response observed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cocaine intoxication is associated with signs of sympathetic overactivity, including elevated blood pressure, tachycardia, diaphoresis, and mydriasis.</span></p>",
      "correct_choice_id": 223809,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14151,
      "choices": [
        {
          "id": 56565,
          "text": "<p><span style=\"font-size:12.0pt;\">Magnetic resonance cholangiopancreatography (MRCP)</span></p>"
        },
        {
          "id": 56566,
          "text": "<p><span style=\"font-size:12.0pt;\">Endoscopic ultrasound</span></p>"
        },
        {
          "id": 56567,
          "text": "<p><span style=\"font-size:12.0pt;\">Percutaneous transhepatic cholangiography</span></p>"
        },
        {
          "id": 56568,
          "text": "<p><span style=\"font-size:12.0pt;\">Endoscopic retrograde cholangiopancreatography</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 72-year-old patient with obstructive jaundice has a distended gall bladder and a dilated common bile duct and intrahepatic biliary radicles on ultrasound. Which of the following will be most useful to localize the cause? (INICET NOV 2021)</span></p>",
      "unique_key": "Q5575376",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682108,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Magnetic resonance cholangiopancreatography (MRCP)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Given scenario of an elderly male with obstructive jaundice and distended gall bladder, is suggestive of periampullary tumour. The best investigation would be a CECT abdomen (not provided in the option) or MRCP.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Correct. MRCP is a non-invasive imaging technique that visualizes the biliary and pancreatic ducts. It provides detailed images without the need for ionizing radiation or invasive procedures. Given the patient's age and presentation, MRCP is an ideal choice to visualize obstructions or abnormalities in the bile duct system without posing additional risks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Endoscopic ultrasound</strong>: This is a useful modality for visualizing the biliary tree, pancreas, and surrounding structures. It can be particularly helpful in assessing small lesions or stones that might be missed by other imaging modalities. It would be utilised if MRCP/CECT did not yield adequate diagnosis, or for staging of periampullary tumors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Percutaneous transhepatic cholangiography:&nbsp;</strong>This is an invasive procedure where contrast is injected directly into the biliary system through the liver, and then X-rays are taken. It can be diagnostic as well as therapeutic (e.g., for bile duct drainage). However, it's more invasive than MRCP and might not be the first choice for solely diagnostic purposes in a 72-year-old patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Endoscopic retrograde cholangiopancreatography (ERCP):&nbsp;</strong>ERCP is both diagnostic and therapeutic. It involves inserting an endoscope through the mouth to the duodenum and injecting contrast into the bile and pancreatic ducts. While ERCP can visualize and treat obstructions, it's invasive and carries risks like pancreatitis, especially if used primarily for diagnostic purposes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Obstructive jaundice is a condition in which there is a blockage of the flow of bile out of the liver. This results in redirection of excess bile and its by-products into the blood, and bile excretion from the body&nbsp;is&nbsp;incomplete</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Symptoms of obstructive jaundice include yellowing of the skin and whites of the eyes; paler stools and darker urine; and intense&nbsp;itching.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most common cause of obstructive jaundice is the presence of CBD stones (choledocholithiasis). Other causes of obstructive jaundice are tumors, trauma, cysts, and inflammation in&nbsp;the&nbsp;bile&nbsp;ducts.</span></p>",
      "correct_choice_id": 56565,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73664,
      "choices": [
        {
          "id": 293597,
          "text": "<p><span style=\"font-size:12.0pt;\">A-3, B-4, C-2, D-1</span></p>"
        },
        {
          "id": 293598,
          "text": "<p><span style=\"font-size:12.0pt;\">A-1, B-2, C-4, D-3</span></p>"
        },
        {
          "id": 293599,
          "text": "<p><span style=\"font-size:12.0pt;\">A-2, B-3, C-1, D-4</span></p>"
        },
        {
          "id": 293600,
          "text": "<p><span style=\"font-size:12.0pt;\">A-4, B-1, C-3, D-2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Match the following: (INICET NOV 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_cnJyaL0.png\" width=\"1104\" height=\"283\"></span></p>",
      "unique_key": "Q5488564",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682158,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) A-3, B-4, C-2, D-1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Mitochondrial inheritance (A) is associated with Leber's disease (3).</strong> Mitochondrial inheritance, also called <strong>maternal inheritance</strong>, occurs when DNA in the mitochondria is passed from <strong>mother to offspring</strong>. Leber's optic neuropathy is a classic example of a mitochondrial disease transmitted through maternal inheritance. This is because <strong>mitochondrial DNA</strong> is present in the ovum but not in sperm.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Zj04d9v.png\" width=\"644\" height=\"372\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>X-linked recessive inheritance (B) is linked to Duchene's muscular dystrophy (4).</strong> In XLR inheritance, the disease is more common in males since they only have one X chromosome. Duchene's muscular dystrophy is specifically listed as an example of X-linked recessive disorders.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Autosomal recessive inheritance (C) corresponds to cystic fibrosis (2).</strong> AR disorders require two copies of the mutated gene to manifest the disease and are common in consanguineous marriages. Cystic fibrosis is a classic example of an autosomal recessive disorder affecting enzymatic proteins.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Trinucleotide repeat disorders (D) include spinobulbar dystrophy (1).</strong> These disorders are characterized by expansion of nucleotide repeats during gametogenesis, leading to neurological diseases. The unstable expansion of trinucleotide repeats (CAG) causes spinobulbar muscular atrophy (Kennedy disease).</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Genetic Disorders and Their Inheritance Patterns</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_1nfl9Rg.png\" width=\"1290\" height=\"335\"></strong></span></p>",
      "correct_choice_id": 293597,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5821,
      "choices": [
        {
          "id": 23254,
          "text": "<p><span style=\"font-size:16px;\">Androgen insensitivity syndrome</span></p>"
        },
        {
          "id": 23255,
          "text": "<p><span style=\"font-size:16px;\">Turner syndrome</span></p>"
        },
        {
          "id": 23256,
          "text": "<p><span style=\"font-size:16px;\">True hermaphrodite</span></p>"
        },
        {
          "id": 23257,
          "text": "<p><span style=\"font-size:16px;\">Swyer's syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A 20-year-old girl presents with primary amenorrhea. On examination breasts were found to be poorly developed, vagina was present. Ultrasound revealed a normal uterus, but gonads weren't detected. Further evaluation done showed 46XY karyotype. The most probable diagnosis?&nbsp;(INICET NOV 2018)</span></p>",
      "unique_key": "Q1278419",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682163,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Swyer's syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The clinical scenario described is indicative of Swyer syndrome, which is characterized by a 46XY karyotype and gonadal dysgenesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Key points about Swyer syndrome:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Swyer syndrome, also known as 46XY gonadal dysgenesis, is a condition where individuals with an XY karyotype present phenotypically as females.</span></li><li><span style=\"font-size:16px;\">These patients have a normal uterus and vagina but lack functioning gonads, which are often termed \"streak gonads.\"</span></li><li><span style=\"font-size:16px;\">Because of gonadal dysgenesis, these individuals do not secrete testosterone or Antimullerian Hormone (AMH), leading to the development of female genital organs and phenotype.</span></li><li><span style=\"font-size:16px;\">Clinical presentation includes primary amenorrhea, absence of secondary sexual characteristics, and female external genitalia despite a 46XY karyotype.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Androgen insensitivity syndrome:</strong> Also known as testicular feminization syndrome, individuals have a 46XY karyotype but are phenotypically female with well-developed breasts and absent axillary and pubic hair. The gonads are testes, and there is no uterus.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Turner syndrome:</strong> Turner syndrome is characterized by a 45XO karyotype. Patients typically present with short stature, shield chest, cubitus valgus, poorly developed secondary sexual characteristics, and streak ovaries.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. True hermaphrodite:</strong> True hermaphrodites have both ovarian and testicular tissue present, which is not consistent with the clinical scenario described.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Swyer syndrome (46XY gonadal dysgenesis) is a condition where individuals with a 46XY karyotype present phenotypically as females with primary amenorrhea, poorly developed secondary sexual characteristics, and a normal uterus but lack functioning gonads.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref: Dutta’s textbook of gynecology 6<sup>th</sup> edition pg 33446, Williams textbook of gynecology 3<sup>rd</sup> edition pg373</strong></span></p>",
      "correct_choice_id": 23257,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14021,
      "choices": [
        {
          "id": 56045,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary, secondary, and tertiary triage</span></p>"
        },
        {
          "id": 56046,
          "text": "<p><span style=\"font-size:12.0pt;\">Immediate, delayed, and minimal triage</span></p>"
        },
        {
          "id": 56047,
          "text": "<p><span style=\"font-size:12.0pt;\">Head neck, thoracic and abdominal triage</span></p>"
        },
        {
          "id": 56048,
          "text": "<p><span style=\"font-size:12.0pt;\">Critical, non-critical, and dead triage</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What are the different levels of triage in emergency care? (INICET MAY 2021)</span></p>",
      "unique_key": "Q7404754",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682133,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Immediate, delayed, and minimal triage</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The different levels of triage in emergency care are <strong>immediate, delayed, and minimal triage.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Immediate triage (red tag)&nbsp;</strong>is the highest priority and is given to patients who have life-threatening injuries or illnesses that require prompt medical attention. Examples of immediate triage include patients with severe bleeding or difficulty breathing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Delayed triage (yellow tag)&nbsp;</strong>is given to patients who have injuries or illnesses that are not immediately life-threatening but require medical attention. Examples of delayed triage include patients with open fractures or moderate burns.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Minimal triage (green tag)&nbsp;</strong>is given to patients who have minor injuries or illnesses that do not require immediate medical attention. Examples of minimal triage include patients with minor cuts or bruises.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Triage helps to ensure that patients receive the appropriate level of care based on their condition and the resources available. By prioritizing patients based on the severity of their injuries or illnesses, emergency medical personnel can provide the best possible care to the greatest number of patients in a disaster or emergency situation.</span></p>",
      "correct_choice_id": 56046,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12827,
      "choices": [
        {
          "id": 51270,
          "text": "<p><span style=\"font-size:12pt;\">Orbicularis oculi, facial muscles, thorax, upper limb</span></p>"
        },
        {
          "id": 51271,
          "text": "<p><span style=\"font-size:12pt;\">Orbicularis oculi, neck, facial muscles, upper limb, thorax</span></p>"
        },
        {
          "id": 51272,
          "text": "<p><span style=\"font-size:12pt;\">Neck, muscles of eyelid, upper limb, thorax</span></p>"
        },
        {
          "id": 51273,
          "text": "<p><span style=\"font-size:12pt;\">Neck, muscles of eyelid, facial muscles, thorax, upper limb</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In what sequence do muscles develop rigor mortis, progressing from early to late? (</span>AIIMS Nov 2017)</p>",
      "unique_key": "Q1597581",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682094,
      "difficulty_level": "intermediate",
      "subjects_id": [
        10
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A. Orbicularis oculi, facial muscles, thorax, upper limb</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Nysten's rule describes the sequential onset of rigor mortis in various muscle groups.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Rigor mortis begins from the head and progresses down the body. The order of appearance of rigor mortis is:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Myocardium</span></li><li><span style=\"font-size:12.0pt;\">Eyelids</span></li><li><span style=\"font-size:12.0pt;\">Neck and lower jaw</span></li><li><span style=\"font-size:12.0pt;\">Face</span></li><li><span style=\"font-size:12.0pt;\">Chest</span></li><li><span style=\"font-size:12.0pt;\">Upper extremities</span></li><li><span style=\"font-size:12.0pt;\">Abdomen</span></li><li><span style=\"font-size:12.0pt;\">Legs</span></li><li><span style=\"font-size:12.0pt;\">Fingers and toes</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Rigor mortis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Rigor mortis is the post-mortem stiffening and contraction of muscles in the body, resulting from the depletion of energy stores, usually becoming noticeable a few hours after death and gradually resolving over time.”</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">It first affects the involuntary muscles first starting with the myocardium</span></li><li><span style=\"font-size:12pt;\">Nysten’s law deals with the progression of rigor mortis in voluntary muscles</span></li><li><span style=\"font-size:12pt;\">Order of appearance of Rigor mortis in different organs:</span></li></ul>",
      "correct_choice_id": 51270,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14368,
      "choices": [
        {
          "id": 57433,
          "text": "<p><span style=\"font-size:12.0pt;\">GIST</span></p>"
        },
        {
          "id": 57434,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenocarcinoma</span></p>"
        },
        {
          "id": 57435,
          "text": "<p><span style=\"font-size:12.0pt;\">Hodgkin’s lymphoma</span></p>"
        },
        {
          "id": 57436,
          "text": "<p><span style=\"font-size:12.0pt;\">Squamous cell carcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old female patient presents to the hospital with complaints of abdominal pain and discomfort for the past few months. The patient also reported experiencing weight loss and loss of appetite. On evaluation, a mass is palpable in the upper abdomen, and an endoscopy shows an ulcerated lesion in the stomach. A biopsy of the lesion is taken and sent for immunohistochemistry. The biopsy sample is found to be positive for CD117 and negative for LCA, cytokeratin, and S100. Based on these findings. What is the most likely diagnosis?</span><span style=\"font-size:11.0pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p>",
      "unique_key": "Q9968504",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682125,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) GIST</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation and the biopsy results suggest the possibility of gastrointestinal stromal tumors (GIST). GIST is the most common mesenchymal tumor of the abdomen, and it typically arises from the interstitial cells of Cajal or the pacemaker cells of the gastrointestinal muscularis propria. GISTs are often associated with symptoms of mass effect, such as abdominal pain and discomfort, and can lead to weight loss and loss of appetite. The diagnosis of GIST is confirmed by immunohistochemistry, which typically shows positivity for KIT (CD117) detectable in Cajal cells. Other immunohistochemical markers such as LCA, cytokeratin, and S100 are negative. Treatment options for GIST may include surgery, radiation therapy, or targeted therapy with tyrosine kinase inhibitors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Adenocarcinoma</strong>: Adenocarcinoma is a common type of cancer that can occur in various organs, including the stomach. However, the immunohistochemistry findings mentioned in the question (positive for CD117 and negative for LCA, cytokeratin, and S100) are not characteristic of adenocarcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Hodgkin’s lymphoma</strong>: Hodgkin's lymphoma is a type of lymphoma that typically presents with enlarged lymph nodes and is characterized by the presence of Reed-Sternberg cells. The immunohistochemistry findings mentioned in the question are not consistent with Hodgkin's lymphoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Squamous cell carcinoma</strong>: Squamous cell carcinoma is commonly associated with the epithelial lining of organs, and its diagnosis would typically involve positive staining for cytokeratin. The immunohistochemistry findings mentioned in the question (negative for cytokeratin) do not support the diagnosis of squamous cell carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">GISTs are mesenchymal tumors that typically occur in the gastrointestinal tract. They often express CD117 (c-kit), a marker commonly associated with GIST. The negative staining for LCA (Leukocyte Common Antigen), cytokeratin, and S100 helps rule out other possibilities and supports the diagnosis of GIST.</span></p>",
      "correct_choice_id": 57433,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31411,
      "choices": [
        {
          "id": 125514,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">DC Cardioversion</span></p>"
        },
        {
          "id": 125515,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Start antiarrhythmic drug</span></p>"
        },
        {
          "id": 125516,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">NAHCO3</span></p>"
        },
        {
          "id": 125517,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient, who consumed a large number of TCA pills during a depressive episode, presented with altered sensorium, hypotension, and wide QRS complexes on ECG. What is the next best step in treatment?&nbsp;(NEET PG 2022)</span></p>",
      "unique_key": "Q7475786",
      "question_audio": null,
      "question_video": null,
      "map_id": 32705196,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) NAHCO3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A patient presenting with altered sensorium, hypotension, and wide QRS complexes on ECG following an overdose of tricyclic antidepressants (TCAs) requires immediate treatment to address the cardiotoxic effects of the overdose. The best next step in this scenario is the administration of <strong>intravenous Sodium Bicarbonate (NAHCO3)</strong>. Sodium Bicarbonate is used to treat the sodium channel blockade caused by TCAs, which is responsible for the wide QRS complexes. It works by alkalinizing the blood, which helps to mitigate the cardiotoxic effects of TCAs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. DC Cardioversion:&nbsp;</strong>This is generally used for unstable patients with life-threatening arrhythmias. In the case of TCA overdose, the priority is to treat the underlying cause of the arrhythmia (the sodium channel blockade), which is more effectively addressed with sodium bicarbonate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Start antiarrhythmic drug:&nbsp;</strong>The use of antiarrhythmic drugs may be risky in the setting of TCA overdose, as these medications can exacerbate the cardiotoxic effects of TCAs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. None of the above:&nbsp;</strong>This is incorrect because there is a clear and specific treatment indicated for this scenario, which is the administration of Sodium Bicarbonate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/23/screenshot-2023-12-23-174426.jpg\" alt=\"\" width=\"1000\" height=\"579\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Kaplan &amp; Sadock’s Synopsis of Psychiatry, 12th edition, Page No 644.</strong></span></p>",
      "correct_choice_id": 125516,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20843,
      "choices": [
        {
          "id": 83336,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Wernicke's Encephalopathy</span></p>"
        },
        {
          "id": 83337,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Korsakoff Syndrome</span></p>"
        },
        {
          "id": 83338,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Delirium Tremens</span></p>"
        },
        {
          "id": 83339,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">De Clerambault Syndrome</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 40-year-old patient with a history of chronic alcohol use presents with complaints of confusion and ataxia. Upon examination, nystagmus and sixth nerve palsy were observed. What is the likely diagnosis?&nbsp; </span>(NEET PG 2023)</p>",
      "unique_key": "Q1203235",
      "question_audio": null,
      "question_video": null,
      "map_id": 32705194,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Wernicke's Encephalopathy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presentation of a 40-year-old patient with a history of chronic alcohol use, who is experiencing confusion, ataxia, nystagmus, and sixth nerve palsy, is highly suggestive of <strong>Wernicke's Encephalopathy</strong>. This is caused by thiamine (vitamin B1) deficiency, commonly seen in individuals with chronic alcohol use. Wernicke's Encephalopathy is characterized by the classic triad of confusion, oculomotor dysfunction (such as nystagmus and cranial nerve palsies), and ataxia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Korsakoff Syndrome:&nbsp;</strong>This is a chronic neuropsychiatric syndrome that often follows Wernicke's Encephalopathy. It is characterized by severe memory impairment, confabulation, and behavioral changes but lacks the acute neurological symptoms such as nystagmus and ataxia seen in Wernicke's Encephalopathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Delirium Tremens:&nbsp;</strong>This is a severe form of alcohol withdrawal characterized by delirium, tremors, agitation, hallucinations, and autonomic instability. While confusion is common, the specific neurological findings of nystagmus and sixth nerve palsy are more indicative of Wernicke's Encephalopathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. De Clerambault Syndrome:&nbsp;</strong>Also known as erotomania, this is a delusional disorder characterized by the belief that another person is in love with the individual. It is unrelated to the symptoms presented in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Wernicke’s encephalopathy is caused by thiamine (vitamin B1) deficiency, which is common in individuals with chronic alcohol use due to poor nutritional intake and absorption. Treatment include high dose of parenteral thiamine. Ophthalmoplegia responds first to the treatment, ataxia doesnt improve completely in almost 50% of cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Kaplan &amp; Sadock’s Synopsis of Psychiatry, 12th edition, Page No 277.</strong></span></p>",
      "correct_choice_id": 83336,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24401,
      "choices": [
        {
          "id": 97565,
          "text": "<p><span style=\"font-size:12.0pt;\">Only 2</span></p>"
        },
        {
          "id": 97566,
          "text": "<p><span style=\"font-size:12.0pt;\">Only 3</span></p>"
        },
        {
          "id": 97567,
          "text": "<p><span style=\"font-size:12.0pt;\">3, 4</span></p>"
        },
        {
          "id": 97568,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is/are correct statement(s) regarding skeletal muscle? (</span>INICET May 2023)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Extracellular calcium entry is important in the skeletal muscle contraction.</span></li><li><span style=\"font-size:12.0pt;\">Calcium is mainly released from mitochondria.</span></li><li><span style=\"font-size:12.0pt;\">Calcium is released from the sarcoplasmic reticulum.</span></li><li><span style=\"font-size:12.0pt;\">Voltage-gated calcium channel on sarcolemma has no role in excitation-contraction coupling.</span></li></ol>",
      "unique_key": "Q2288355",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682161,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><strong>Ans. B. Only 3</strong></p><p>&nbsp;</p><p>The accurate fact concerning skeletal muscle is that the release of calcium occurs from the sarcoplasmic reticulum only.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p>1. Extracellular calcium plays a significant role in sustaining cardiac muscle contraction , not in skeletal muscle.</p><p>&nbsp;</p><p>2. The sarcoplasmic reticulum is filled with high concentrations of calcium ions stored in its vesicular tubules. Upon the occurrence of an action potential in the neighboring T tubule, these calcium ions are discharged from each vesicle.</p><p>&nbsp;</p><p>4. Activation of &nbsp;voltage-gated calcium channel is essential in excitation-contraction coupling, i.e. it a has important role. Activation of receptor results in the initiation of calcium release from RyR channels, leading to the liberation of calcium ions from the sarcoplasm surrounding the myofibrils, consequently triggering muscle contraction.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p>The release of calcium from the sarcoplasmic reticulum is essential for skeletal muscle contraction.</p>",
      "correct_choice_id": 97566,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10201,
      "choices": [
        {
          "id": 40770,
          "text": "<p><span style=\"font-size:12pt;\">Scrub typhus</span></p>"
        },
        {
          "id": 40771,
          "text": "<p><span style=\"font-size:12pt;\">Kyasanur Forest Disease (KFD)</span></p>"
        },
        {
          "id": 40772,
          "text": "<p><span style=\"font-size:12pt;\">Cutaneous anthrax</span></p>"
        },
        {
          "id": 40773,
          "text": "<p><span style=\"font-size:12pt;\">Healing brown recluse spider bite</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following differentials should not be considered for the lesion seen in the image developed in a forest officer?(INICET NOV 2021)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13551.jpg\" alt=\"\" width=\"300\" height=\"177\"></p>",
      "unique_key": "Q4750801",
      "question_audio": null,
      "question_video": null,
      "map_id": 32705481,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;B) Kyasanur Forest Disease (KFD)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Eschar&nbsp;</strong>can be noted in the given image, and <strong>Kyasanur Forest Disease (KFD)</strong> is <strong>not</strong> a possible differential diagnosis for <strong>eschar.</strong></span></p><ul><li><span style=\"font-size:12pt;\">KFD is a <strong>tick-borne</strong> viral <strong>hemorrhagic fever</strong> endemic in <strong>South India.</strong></span></li><li><span style=\"font-size:12pt;\">The primary clinical manifestations of KFD are <strong>fever, headache, severe muscle pain,</strong> followed by <strong>haemorrhagic symptoms</strong> like haemorrhages in the skin, mucosa &amp; viscera, <strong>petechial lesions</strong> are characteristic skin lesions observed.</span></li><li><span style=\"font-size:12pt;\">It is more known for its <strong>neurological</strong> and <strong>hemorrhagic </strong>manifestations but <strong>NOT Eschar.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A: Scrub typhus (chigger-borne typhus)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The infective agent of scrub typhus, <strong>Orientia tsutsugamushi</strong> (Previously known as <strong>Rickettsia tsutsugamushi</strong>), is conveyed to humans from its natural <strong>rodent reservoir</strong> by the bites of the <strong>Trombiculid mite</strong>.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13551_WCHoZls.jpg\" alt=\"\" width=\"400\" height=\"237\"></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Humans are infected when they are bitten by the <strong>mite larvae</strong> known as <strong>chiggers</strong>.</span></li><li><span style=\"font-size:12pt;\">The <strong>incubation period is 1- 3 weeks</strong>. The primary lesion, or eschar, is a firm papule up to 1 mm in diameter surmounted by a vesicle, which dries to form a black crust.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C:</strong>&nbsp;<strong>Cutaneous anthrax</strong> (<strong>Hide porters’ disease</strong>)</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Anthrax is a <strong>zoonotic</strong> infection with <strong>Bacillus anthracis.</strong></span></li><li><span style=\"font-size:12pt;\">Between 1 and 5 days after infection, an irritable papule develops at the site of inoculation. A bulla on a red oedematous base soon follows.</span></li><li><span style=\"font-size:12pt;\">The bulla ruptures and forms a <strong>haemorrhagic crust which will undergo necrosis</strong>. Surrounding this several <strong>satellite lesions</strong> filled with serum or yellow fluid are arranged around a <strong>central necrotic</strong> lesion which is covered by a <strong>black eschar.</strong></span></li><li><span style=\"font-size:12pt;\">This is called as <strong>Malignant pustule as shown in the image below</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture28.jpg\" alt=\"\" width=\"300\" height=\"271\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D: Healing brown recluse spider bite.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Bite of&nbsp;<strong>Loxosceles reclusa (Loxoscelism</strong>) → <strong>Target lesion</strong> develops → Development of <strong>eschar</strong> → Heals with <strong>Ulcer </strong>formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Kyasanur Forest Disease tick-borne&nbsp;</strong>viral <strong>hemorrhagic fever, </strong>primarily presenting with <strong>haemorrhagic and neurological </strong>symptoms, should <strong>not</strong> be considered for skin lesion, Eschar, unlike the other mentioned differentials.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref - Rooks textbook of dermatology- 9<sup>th</sup> Edition Chapter 34 page no 34.33</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Ananthanarayan &amp; Paniker’s textbook of Microbiology 10<sup>th</sup> edition Page no 249, 250, 415, 530</strong></span></p>",
      "correct_choice_id": 40771,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6117,
      "choices": [
        {
          "id": 24437,
          "text": "<p><span style=\"font-size:12.0pt;\">Desire</span></p>"
        },
        {
          "id": 24438,
          "text": "<p><span style=\"font-size:12.0pt;\">Arousal</span></p>"
        },
        {
          "id": 24439,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Orgasm</span></p>"
        },
        {
          "id": 24440,
          "text": "<p><span style=\"font-size:12.0pt;\">Pain</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Premature ejaculation is a disorder of which phase of the normal sexual cycle? (NEET PG 2019)</span></p>",
      "unique_key": "Q6537372",
      "question_audio": null,
      "question_video": null,
      "map_id": 32705380,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Orgasm</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This phase involves the release of sexual tension. Premature ejaculation and anorgasmia are disorders of this phase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Premature ejaculation is a disorder of the orgasm phase of the sexual response cycle. It involves ejaculation that occurs earlier than desired, often with minimal sexual stimulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Desire:</strong> This phase refers to the interest in engaging in sexual activity. Disorders of this phase might manifest as hypoactive sexual desire disorder or sexual aversion disorder.</span></p><p><span style=\"font-size:11pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Arousal:</strong> This phase is characterized by physiological changes such as erection in men and vaginal lubrication in women. Erectile dysfunction is a disorder of this phase in men.</span></p><p><span style=\"font-size:11pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pain:</strong> This isn't a phase of the sexual response cycle. However, dyspareunia refers to pain during intercourse and can be a clinical condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Premature ejaculation is a disorder of the orgasm phase of the sexual response cycle. It is characterized by a pattern of persistent or recurrent ejaculation with minimal sexual stimulation before or immediately after the vaginal penetration.</span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Kaplan &amp; Sadock’s Synopsis of Psychiatry, 11th edition, Page No 579.</strong></span></p>",
      "correct_choice_id": 24439,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7046,
      "choices": [
        {
          "id": 28152,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Protamine sulphate</span></span></span></p>"
        },
        {
          "id": 28153,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dalteparin</span></span></span></p>"
        },
        {
          "id": 28154,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epsilon Amino Caproic Acid</span></span></span></p>"
        },
        {
          "id": 28155,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alteptase</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is the antidote for fibrinolytic therapy? (</span></span>INICET May 2020)</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>",
      "unique_key": "Q6880598",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682156,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Epsilon Amino Caproic Acid</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fibrinolytic therapy involves the use of drugs (like alteplase, streptokinase, etc.) to break down blood clots. Epsilon Amino Caproic Acid (EACA) and tranexamic acid are antifibrinolytic agents that can be used to counteract bleeding due to excessive fibrinolysis, which can occur during or after fibrinolytic therapy. These work by inhibiting plasminogen activators and, to a lesser degree, plasmin activity, thereby reducing the breakdown of fibrin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Protamine Sulphate:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is used as an antidote for heparin overdose, not for fibrinolytic therapy. Protamine sulphate binds to and inactivates heparin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Dalteparin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Dalteparin is a low molecular weight heparin and is an anticoagulant itself. It is not used as an antidote for fibrinolytic therapy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Alteplase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Alteplase is a fibrinolytic agent, not an antidote. It is used to dissolve blood clots in conditions like acute ischemic stroke, pulmonary embolism, and myocardial infarction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epsilon Amino Caproic Acid is the antidote for fibrinolytic therapy, used to counteract excessive bleeding due to fibrinolysis. It works by inhibiting plasminogen activators and stabilizing clots.</span></span></span></p>",
      "correct_choice_id": 28154,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73121,
      "choices": [
        {
          "id": 291445,
          "text": "<p><span style=\"font-size:16px;\">Plasma sterilization</span></p>"
        },
        {
          "id": 291446,
          "text": "<p><span style=\"font-size:16px;\">Gamma rays</span></p>"
        },
        {
          "id": 291447,
          "text": "<p><span style=\"font-size:16px;\">UV rays</span></p>"
        },
        {
          "id": 291448,
          "text": "<p><span style=\"font-size:16px;\">Autoclave&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">All of the following methods of cold sterilization except: (INICET NOV 2024)</span></p>",
      "unique_key": "Q3640241",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682131,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Autoclave</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Cold sterilization refers to sterilization methods that do not involve heat application. <strong>Autoclave operates at 121°C for 15 minutes at 15 PSI pressure,</strong> making it a <strong>hot sterilization</strong> method rather than a cold sterilization technique.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>&nbsp;Option A. Plasma sterilization:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">This is a valid cold sterilization method</span></li><li><span style=\"font-size:16px;\">Uses gases in plasma state without temperature increase</span></li><li><span style=\"font-size:16px;\">Effective for heat-sensitive materials</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Gamma rays:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Valid cold sterilization method</span></li><li><span style=\"font-size:16px;\">Uses ionizing radiation</span></li><li><span style=\"font-size:16px;\">Does not increase temperature</span></li><li><span style=\"font-size:16px;\">Commonly used for medical devices and supplies</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. UV rays:&nbsp;</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Valid cold sterilization method</span></li><li><span style=\"font-size:16px;\">Uses non-ionizing radiation</span></li><li><span style=\"font-size:16px;\">Does not generate heat</span></li><li><span style=\"font-size:16px;\">Effective for surface sterilization</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Autoclave is a hot sterilization method operating at 121°C for 15 minutes at 15 PSI pressure, while plasma sterilization, gamma rays, and UV rays are cold sterilization methods that do not involve heat application.</span></p>",
      "correct_choice_id": 291448,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6126,
      "choices": [
        {
          "id": 24473,
          "text": "<p><span style=\"font-size:12.0pt;\">Acarophobia</span></p>"
        },
        {
          "id": 24474,
          "text": "<p><span style=\"font-size:12.0pt;\">Algophobia</span></p>"
        },
        {
          "id": 24475,
          "text": "<p><span style=\"font-size:12.0pt;\">Agoraphobia</span></p>"
        },
        {
          "id": 24476,
          "text": "<p><span style=\"font-size:12.0pt;\">Acrophobia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the fear of heights known as?(NEET PG &nbsp;2019)</span></p>",
      "unique_key": "Q6282287",
      "question_audio": null,
      "question_video": null,
      "map_id": 32705377,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Acrophobia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is the fear of heights.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Acarophobia: </strong>This is the fear of itching or of the insects that cause itching.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Algophobia: </strong>This is the fear of pain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Agoraphobia: </strong>This is the fear of open spaces or of being in crowded, public places like markets, or the fear of leaving a safe place, often associated with panic attacks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acrophobia refers to the fear of heights.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/12/untitled-358.jpg\" alt=\"\" width=\"1000\" height=\"500\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Kaplan &amp; Sadock’s Synopsis of Psychiatry, 11th edition, Page No 403.</strong></span></p>",
      "correct_choice_id": 24476,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6124,
      "choices": [
        {
          "id": 24465,
          "text": "<p><span style=\"font-size:12.0pt;\">Pathological doubt</span></p>"
        },
        {
          "id": 24466,
          "text": "<p><span style=\"font-size:12.0pt;\">Magical thinking</span></p>"
        },
        {
          "id": 24467,
          "text": "<p><span style=\"font-size:12.0pt;\">Hoarding</span></p>"
        },
        {
          "id": 24468,
          "text": "<p><span style=\"font-size:12.0pt;\">Contamination obsession</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following has a poor prognosis with exposure and response prevention in OCD?&nbsp;</span>( NEET PG 2019)</p>",
      "unique_key": "Q6394692",
      "question_audio": null,
      "question_video": null,
      "map_id": 32705378,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Hoarding</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Among the OCD subtypes, hoarding has shown to be more resistant to treatment with ERP. This might be because individuals with hoarding disorder often do not recognize their behavior as problematic and may lack insight into the disorder.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Exposure and response prevention (ERP) is a type of cognitive-behavioral therapy that is effective for many individuals with obsessive-compulsive disorder (OCD). However, certain subtypes or themes of OCD might respond less effectively to ERP.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pathological doubt:</strong> While challenging, ERP can be tailored to address pathological doubt by creating exposures that trigger doubt without seeking reassurance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Magical thinking:</strong> ERP can also be adapted for magical thinking by exposing the individual to the feared situation or thought without engaging in the ritualistic behavior.</span></p><p>&nbsp;</p><p><strong>Option&nbsp;</strong><span style=\"font-size:12.0pt;\"><strong>D. Contamination obsession:</strong> Contamination fears are typically one of the subtypes that respond quite well to ERP, as the therapist can create direct exposures involving the feared contaminant.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hoarding disorder is characterised by acquiring and not being able to discard things that are considered to have little or no use. This will lead to cluttering of house, to an extent that it becomes unsafe to live. This disorder is driven by fear of losing something important. Treatment includes SSRIs and CBT.&nbsp; Hoarding disorder tends to have a <strong>poorer prognosis with exposure and response prevention compared to other subtypes</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Kaplan &amp; Sadock’s Synopsis of Psychiatry, 11th edition, Page No 431.</strong></span></p>",
      "correct_choice_id": 24467,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23199,
      "choices": [
        {
          "id": 92760,
          "text": "<p><span style=\"font-size:12.0pt;\">Short arm of Y chromosome</span></p>"
        },
        {
          "id": 92761,
          "text": "<p><span style=\"font-size:12.0pt;\">Short arm of X chromosome</span></p>"
        },
        {
          "id": 92762,
          "text": "<p><span style=\"font-size:12.0pt;\">Long arm of Y chromosome</span></p>"
        },
        {
          "id": 92763,
          "text": "<p><span style=\"font-size:12.0pt;\">Long arm of X chromosome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Where is the SRY region located?</span></p>",
      "unique_key": "Q3102851",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682115,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Short arm of Y chromosome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The SRY gene is located on the short arm (p-arm) of the Y chromosome (Yp11). This gene is often referred to as the \"master switch\" for male development. It codes for a transcription factor that triggers the development of testes in an embryo, which, in turn, leads to the development of male reproductive structures.</span></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">It is an intron less sex-determining gene on the Y chromosome.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/04/anotmy-11.jpg\" alt=\"\" width=\"500\" height=\"302\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Y- chromosome&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The SRY (Sex-determining Region Y) gene is a critical genetic region responsible for initiating male sex determination and the development of male reproductive organs in mammals, including humans. Let's discuss the location of the SRY region in detail for each option:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B) Short arm of X chromosome: </strong>Incorrect. The SRY gene is not located on the X chromosome. It is specific to the Y chromosome and plays a pivotal role in male sex determination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C) Long arm of Y chromosome: </strong>Incorrect. The SRY gene is not on the long arm (q-arm) of the Y chromosome. It is situated on the short arm, as mentioned earlier.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D) Long arm of X chromosome: </strong>Incorrect. The SRY gene is not present on the X chromosome. It is unique to the Y chromosome and is responsible for the differentiation of the bipotential gonad into the testis during early embryonic development.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sex- determining region Y protein (SRY) gene or TDF ( Testis-determining factor ) is a DNA binding protein encoded by the SRY gene that is responsible for the initiation of male sex determination in mammals. Its expression causes the development of primary sex cords, which later develop into seminiferous tubules.</span></p>",
      "correct_choice_id": 92760,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6222,
      "choices": [
        {
          "id": 24857,
          "text": "<p><span style=\"font-size:12.0pt;\">Panic disorder</span></p>"
        },
        {
          "id": 24858,
          "text": "<p><span style=\"font-size:12.0pt;\">Conversion disorder</span></p>"
        },
        {
          "id": 24859,
          "text": "<p><span style=\"font-size:12.0pt;\">Social anxiety disorder</span></p>"
        },
        {
          "id": 24860,
          "text": "<p><span style=\"font-size:12.0pt;\">Generalized anxiety disorder</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A first year MBBS student presented to OPD with intermittent episodes of impending doom accompanied by profuse sweating. The episodes usually occur before her exams. What is the most likely cause? (NEET PG 2020)</span></p>",
      "unique_key": "Q1657938",
      "question_audio": null,
      "question_video": null,
      "map_id": 32705202,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Panic disorder</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The symptoms described are indicative of panic attacks, which are sudden periods of intense fear or discomfort that may include palpitations, sweating, trembling or shaking, and feelings of impending doom. These attacks can occur unexpectedly or in anticipation of a specific trigger, such as before an exam.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.</strong> <strong>Conversion disorder</strong> is characterized by neurological symptoms not explained by a neurological disease or other medical condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong> <strong>Social anxiety disorder</strong> is characterized by an intense fear of social situations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>Generalized anxiety disorder</strong> involves excessive anxiety and worry about multiple events or activities most days for at least 6 months, not limited to performance situations like exams.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Panic disorder is characterized by recurrent episodes of panic attack. Panic attack is a sudden, intense episode of fear or discomfort often accompanied by <strong>a sensation of impending doom</strong>. The symptoms during panic attack usually involve sudden onset of <strong>palpitations, chest pain, choking sensations,</strong> dizziness and feeling of unreality (depersonalization or derealization).Along with these physical symptoms there is also <strong>fear of dying, losing control </strong>or <strong>going mad</strong>.</span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Kaplan &amp; Sadock’s Synopsis of Psychiatry, 11th edition, Page No 394.</strong></span></p>",
      "correct_choice_id": 24857,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61177,
      "choices": [
        {
          "id": 243989,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 2, 3</span></span></span></span></p>"
        },
        {
          "id": 243990,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 3, 4</span></span></span></span></p>"
        },
        {
          "id": 243991,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2, 3, 4</span></span></span></span></p>"
        },
        {
          "id": 243992,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 2, 4</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BRCA 1 gene is associated with______:</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Repair of ds DNA break</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Risk of development of ovarian cancer</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tumor suppressor gene</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mutation is seen in the subset of Fanconi anemia</span></span></span></span></li>\r\n</ol>",
      "unique_key": "Q7680263",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682113,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) 1, 2, 3</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The statements associated with the <strong>BRCA1 gene</strong> are:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Repair of double-stranded (ds) DNA breaks:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BRCA1 plays a critical role in the repair process of ds DNA breaks through homologous recombination.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Risk of development of ovarian cancer:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Women with mutations in the BRCA1 gene have a higher risk of developing ovarian cancer, in addition to breast cancer.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tumor suppressor gene:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BRCA1 is classified as a tumor suppressor gene, meaning it helps to prevent uncontrolled cell division and tumor growth by repairing DNA damage.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Both <strong>BRCA1</strong> and <strong>BRCA2</strong> are tumor suppressor genes that protect against certain cancers. Mutations in these genes increase the risk of breast and ovarian cancers, especially in women. They also play an essential role in the repair of DNA damage through homologous recombination, which fixes double-strand DNA breaks.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mutations in <strong>BRCA1</strong> do not commonly cause Fanconi anemia, although mutations in <strong>BRCA2</strong> are more commonly linked to a subset of Fanconi anemia.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. 1,3,4:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While BRCA1 is associated with DNA repair and is a tumor suppressor gene, it is not commonly linked to Fanconi anemia, which is more associated with BRCA2 mutations.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. 2,3,4:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Although the BRCA1 mutation increases the risk of ovarian cancer and functions as a tumor suppressor, its connection to Fanconi anemia is more relevant to BRCA2 mutations, not BRCA1.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. 1,2,4:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While BRCA1 plays a role in DNA repair and is linked to ovarian cancer risk, it is not associated with Fanconi anemia.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BRCA1&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a tumor suppressor gene primarily associated with the <strong>repair of double-stranded DNA breaks</strong>, the <strong>development of breast and ovarian cancer</strong>, and it functions to suppress tumor formation. <strong>BRCA2</strong> mutations are more commonly linked to <strong>Fanconi anemia</strong>.</span></span></span></span></p>",
      "correct_choice_id": 243989,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54873,
      "choices": [
        {
          "id": 218953,
          "text": "<p><span style=\"font-size:12.0pt;\">Pupil dilatation</span></p>"
        },
        {
          "id": 218954,
          "text": "<p><span style=\"font-size:12.0pt;\">Ptosis</span></p>"
        },
        {
          "id": 218955,
          "text": "<p><span style=\"font-size:12.0pt;\">Down and out eye</span></p>"
        },
        {
          "id": 218956,
          "text": "<p><span style=\"font-size:12.0pt;\">Abduction limitation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which is not a feature of 3rd nerve palsy? (INICET MAY 2024)</span></p>",
      "unique_key": "Q5412244",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682110,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Abduction limitation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is not a feature of third nerve palsy. Abduction of the eye is controlled by the lateral rectus muscle, which is innervated by the sixth cranial nerve. Limitation in abduction is indicative of sixth nerve palsy, not third nerve palsy. In third nerve palsy, there would be a limitation of adduction (movement of the eye towards the nose) instead.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Third nerve palsy (oculomotor nerve palsy) presents with several characteristic features due to the loss of function of the muscles it innervates:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pupil dilatation:</strong> The third cranial nerve carries parasympathetic fibers responsible for pupil constriction. Damage to this nerve results in unopposed sympathetic stimulation, leading to pupil dilatation (mydriasis).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ptosis:</strong> The levator palpebrae superioris muscle, responsible for elevating the eyelid, is innervated by the third cranial nerve. Damage to this nerve causes ptosis (drooping of the eyelid).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Down and out eye:</strong> The unopposed action of the lateral rectus (innervated by the sixth cranial nerve) and the superior oblique (innervated by the fourth cranial nerve) results in the characteristic \"down and out\" position of the affected eye.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Third nerve palsy presents with pupil dilatation, ptosis, and a down and out eye. Abduction limitation is not a feature of third nerve palsy; it is seen in sixth nerve palsy.</span></p>",
      "correct_choice_id": 218956,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5742,
      "choices": [
        {
          "id": 22940,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Conisation</span></span></span></p>"
        },
        {
          "id": 22941,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cryotherapy</span></span></span></p>"
        },
        {
          "id": 22942,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Targeted biopsy</span></span></span></p>"
        },
        {
          "id": 22943,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pap smear</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old woman comes with a history of postcoital bleeding and a visible mass seen in cervix per speculum. The next step to be done?&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET NOV 2017)</span></span></span></span></p>",
      "unique_key": "Q1181897",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682123,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Targeted biopsy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A targeted biopsy (punch biopsy) is the next line of management in the above case as the patient is symptomatic (postcoital bleeding) and has a visible lesion. This approach allows for the direct sampling of the lesion to assess for malignancy or other pathological changes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Conisation:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Conisation is an excisional procedure that is typically performed once biopsy-proven cervical intraepithelial neoplasia (CIN 2 and 3) is diagnosed. It is not the initial step for a visible mass with postcoital bleeding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Cryotherapy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Cryotherapy is an ablative procedure used for treating CIN1 or 2. It is not suitable for initial diagnosis or for lesions suspected of being malignant.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Pap smear:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A Pap smear is done when there are symptoms with no identifiable lesion. It is a screening tool and not diagnostic for a visible lesion with postcoital bleeding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a symptomatic patient with a visible cervical lesion and postcoital bleeding, a targeted biopsy is the appropriate next step to obtain a definitive diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 327, DC Dutta&rsquo;a Textbook of gynecology, 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 22942,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6120,
      "choices": [
        {
          "id": 24449,
          "text": "<p><span style=\"font-size:12.0pt;\">Delirium</span></p>"
        },
        {
          "id": 24450,
          "text": "<p><span style=\"font-size:12.0pt;\">Dementia</span></p>"
        },
        {
          "id": 24451,
          "text": "<p><span style=\"font-size:12.0pt;\">Schizophrenia</span></p>"
        },
        {
          "id": 24452,
          "text": "<p><span style=\"font-size:12.0pt;\">Depression</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Confusion assessment test is used in:(NEET PG 2019)</span></p>",
      "unique_key": "Q1102118",
      "question_audio": null,
      "question_video": null,
      "map_id": 32705379,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Delirium</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Confusion Assessment Method (often referred to as CAM) is a diagnostic tool specifically designed to identify delirium.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CAM is used primarily for the detection of delirium, especially in hospitalized or elderly patients. It evaluates features like acute onset and fluctuating course, inattention, disorganized thinking, and altered level of consciousness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Dementia:</strong> While CAM can help differentiate delirium from dementia, it is not specifically designed for the diagnosis of dementia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Schizophrenia:</strong> CAM is not used in the diagnosis or assessment of schizophrenia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Depression: </strong>CAM is not used in the diagnosis or assessment of depression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Confusion Assessment Method (CAM) is a tool specifically developed to detect delirium. Bedside examinations such as <strong>mini mental status examination (MMSE) </strong>are used to provide a measure of cognitive impairment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Kaplan &amp; Sadock’s Synopsis of Psychiatry, 11th edition, Page No 701.</strong></span></p>",
      "correct_choice_id": 24449,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12931,
      "choices": [
        {
          "id": 51686,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Gunshot wound</span></p>"
        },
        {
          "id": 51687,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Tattooing</span></p>"
        },
        {
          "id": 51688,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Arsenic poisoning</span></p>"
        },
        {
          "id": 51689,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Graze wound</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Identify the image shown below. (</span>INICET Nov 2020)</p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-27.jpg\" alt=\"\" width=\"400\" height=\"518\"></span></p>",
      "unique_key": "Q8592316",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682129,
      "difficulty_level": "beginner",
      "subjects_id": [
        10
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. A. Gunshot wound</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The given image is of a gunshot wound.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Features of gunshot wound:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Central round hole with surrounding soot soiling.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Burnt hairs (singeing).</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Punctate skin lesions from powder particles (tattooing).</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Bevelling of edges (Exit Wounds)</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Tattooing: </strong>While tattooing refers to punctate skin lesions caused by powder particles in gunshot wounds, it alone does not describe the entirety of the image shown.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Arsenic poisoning: </strong>Arsenic poisoning typically causes symptoms like skin changes, but not the characteristic central hole and surrounding soot seen in gunshot wounds.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Graze wound: </strong>A graze wound is typically a superficial wound caused by the bullet skimming the surface of the skin, which looks different from the wound shown in the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A gunshot wound can be identified by its central round hole, surrounding soot, singeing of hairs, tattooing from powder particles, and bevelling of the wound edges.</span></p>",
      "correct_choice_id": 51686,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12560,
      "choices": [
        {
          "id": 50203,
          "text": "<p><span style=\"font-size:12.0pt;\">Erythroxylum coca</span></p>"
        },
        {
          "id": 50204,
          "text": "<p><span style=\"font-size:12.0pt;\">Datura</span></p>"
        },
        {
          "id": 50205,
          "text": "<p><span style=\"font-size:12.0pt;\">Digitalis Purpura</span></p>"
        },
        {
          "id": 50206,
          "text": "<p><span style=\"font-size:12.0pt;\">Cannabis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the plant which produces a toxin of abuse potential? (</span>AIIMS May 2019)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/28/image-9.jpg\" alt=\"\" width=\"400\" height=\"258\"></span></p>",
      "unique_key": "Q4837262",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682100,
      "difficulty_level": "beginner",
      "subjects_id": [
        10
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Erythroxylum coca</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The plant in the picture is Erythroxylum coca, which can be identified by red berries.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cocaine, a substance with significant abuse potential, is derived from this plant.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B Datura:</strong> It can be identified by:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Green color fruit with sharp spines</span></li><li><span style=\"font-size:12.0pt;\">Large trumpet shaped flowers</span></li></ul><p style=\"margin-left:24px;\">&nbsp;</p><p style=\"margin-left:24px;\"><span style=\"font-size:12.0pt;\">Datura flower and fruit images shown below:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/screenshot-2023-09-27-104418.jpg\" alt=\"\" width=\"700\" height=\"290\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C Digitalis Purpura:&nbsp;</strong>It can be identified by:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"background-color:white;color:#202122;font-size:12pt;\">Leaves are spirally arranged and covered with gray-white hairs, imparting a woolly texture.</span></li><li><span style=\"background-color:white;color:#202122;font-size:12pt;\">Flowers are arranged in an elongated cluster, and each flower is tubular and pendent.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Digitalis purpura Flower and Plant images shown below:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/screenshot-2023-09-27-104520.jpg\" alt=\"\" width=\"700\" height=\"280\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D Cannabis:&nbsp;</strong>It can be identified by:<strong>&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Leaves have a digitate shape, with serrated edges. Leaflets are arranged opposite each other along the stem and are usually symmetrically aligned.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cannabis leaves images shown below:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/screenshot-2023-09-27-104614.jpg\" alt=\"\" width=\"700\" height=\"213\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cocaine is obtained from Erythroxylum coca, which can be identified by following features:</span></p><p>&nbsp;</p><ul><li><span style=\"background-color:white;color:#202122;font-size:12pt;\"><strong>Leaves</strong>: Characteristic of the leaf is an areolated portion bounded by two longitudinal curved lines, one line on each side of the midrib.</span></li><li><span style=\"background-color:white;color:#202122;font-size:12pt;\"><strong>Flowers&nbsp;</strong>are small, and disposed in little clusters on short stalks.</span></li><li><span style=\"background-color:white;color:#202122;font-size:12pt;\"><strong>Red Berries:&nbsp;</strong>The flowers mature into red&nbsp;berries.</span></li></ul>",
      "correct_choice_id": 50203,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60834,
      "choices": [
        {
          "id": 242629,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3 and 4 </span></span></span></p>"
        },
        {
          "id": 242630,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 2 and 3 </span></span></span></p>"
        },
        {
          "id": 242631,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2, 3 and 4 </span></span></span></p>"
        },
        {
          "id": 242632,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Only 4 </span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Consider the causes of alopecia. Which among the following cause(s) non-scarring alopecia? (INICET NOV 2022) </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alopecia areata</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Telogen effluvium</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Androgenic alopecia</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Frontal fibrosing alopecia</span></span></span></li>\r\n</ol>",
      "unique_key": "Q7441994",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682114,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) 1, 2 and 3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Non-scarring alopecia is caused by </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">androgenic alopecia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">alopecia areata</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, and </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">telogen effluvium</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (1, 2, and 3). </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Frontal fibrosing alopecia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a type of </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">primary cicatricial (scarring) alopecia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alopecia areata</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a chronic inflammatory disease causing </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">non-scarring hair loss</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. It is a </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">T-cell-mediated inflammatory disease</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> associated with several autoimmune conditions, including </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">thyroiditis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">lupus erythematosus</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">vitiligo</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, and </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">psoriasis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. It mainly affects the </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">scalp</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, but may also involve the </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">beard, eyebrows, and eyelashes</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. In some cases, it can lead to total hair loss on the scalp (</span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">alopecia totalis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">) or the entire body (</span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">alopecia universalis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Telogen effluvium</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a type of non-scarring alopecia marked by </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">diffuse shedding</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> of normal hair due to the </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">premature termination</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> of the anagen phase of the hair cycle. It can be either acute or chronic:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute telogen effluvium</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> typically occurs 2&ndash;3 months after stressful events such as high fever, surgery, or postpartum hormonal changes (</span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">telogen gravidarum</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">). This condition often resolves spontaneously.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic telogen effluvium</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> persists for more than six months and is often associated with </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">thyroid disorders</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">iron-deficiency anemia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, or </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">malnutrition</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Androgenetic alopecia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a non-scarring alopecia characterized by a reduction in hair fiber production and follicle miniaturization. It is related to </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">dihydrotestosterone (DHT)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, an androgenic metabolite, and has two forms:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Male-pattern hair loss</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> typically causes frontal hairline recession and vertex thinning.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Female-pattern hair loss</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> results in mid-frontal scalp thinning with minimal involvement of the temporal region.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Frontal fibrosing alopecia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, on the other hand, is a type of </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">scarring (cicatricial) alopecia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, leading to permanent hair loss due to follicular destruction.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. 3 and 4: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">androgenic alopecia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (option 3) causes non-scarring alopecia, </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">frontal fibrosing alopecia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (option 4) is a scarring form of alopecia, making this option incorrect.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. 2, 3, and 4: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Although </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">telogen effluvium</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (option 2) and </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">androgenic alopecia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (option 3) are types of non-scarring alopecia, </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">frontal fibrosing alopecia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (option 4) is scarring, which makes this option incorrect.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Only 4: Frontal fibrosing alopecia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a scarring type of alopecia, so it cannot be classified as non-scarring, making this option incorrect.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Non-scarring alopecia includes </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">androgenic alopecia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">alopecia areata</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, and </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">telogen effluvium</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. These conditions result in hair loss that does not involve permanent destruction of the hair follicles, distinguishing them from scarring types of alopecia like </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">frontal fibrosing alopecia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.</span></span></span></p>",
      "correct_choice_id": 242630,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 63701,
      "choices": [
        {
          "id": 254009,
          "text": "<p><span style=\"font-size:12.0pt;\">Potassium channel blocker</span></p>"
        },
        {
          "id": 254010,
          "text": "<p><span style=\"font-size:12.0pt;\">Sodium channel blocker</span></p>"
        },
        {
          "id": 254011,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium channel blocker</span></p>"
        },
        {
          "id": 254012,
          "text": "<p><span style=\"font-size:12.0pt;\">Chlorine channel blocker</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of the following actions leads to an increase in acetylcholine (ACh) release from the presynaptic neuron?</span></p>",
      "unique_key": "Q6279415",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682160,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Potassium channel blocker</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Potassium channel blockers increase acetylcholine (ACh) release from the presynaptic neuron. Blocking potassium channels prolongs depolarization of the neuron, which enhances the influx of calcium through voltage-gated calcium channels. This increased calcium entry then promotes greater ACh release at the neuromuscular junction.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Aminopyridines, which are potassium channel blockers, are used in the treatment of Lambert-Eaton myasthenic syndrome to improve muscle strength by increasing ACh release.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option&nbsp;B. Sodium channel blocker:</strong> Blocking sodium channels would reduce neuronal depolarization, thus decreasing calcium entry and subsequently reducing ACh release.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option&nbsp;C. Calcium channel blocker:</strong> Blocking calcium channels would directly prevent calcium influx, leading to a decrease in ACh release from the presynaptic neuron.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option&nbsp;D. Chlorine channel blocker:</strong> Chlorine (chloride) channels do not directly affect ACh release. Chloride ions typically stabilize the membrane potential, so blocking them would not specifically increase ACh release.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Potassium channel blockers enhance acetylcholine release by prolonging neuronal depolarization and increasing calcium influx at the presynaptic terminal.</span></p>",
      "correct_choice_id": 254009,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6154,
      "choices": [
        {
          "id": 24585,
          "text": "<p><span style=\"font-size:12.0pt;\">Obsession</span></p>"
        },
        {
          "id": 24586,
          "text": "<p><span style=\"font-size:12.0pt;\">Derailment</span></p>"
        },
        {
          "id": 24587,
          "text": "<p><span style=\"font-size:12.0pt;\">Delusion</span></p>"
        },
        {
          "id": 24588,
          "text": "<p><span style=\"font-size:12.0pt;\">Thought insertion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a formal thought disorder?&nbsp;(NEET PG 2021)</span></p>",
      "unique_key": "Q1563652",
      "question_audio": null,
      "question_video": null,
      "map_id": 32705198,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Derailment</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Formal thought disorders refer to abnormalities in the organization, associations and connections of the thought, rather than the content of thought.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Here, the association between two successive thoughts is disturbed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Obsession:</strong> It refers to recurrent, intrusive, and unwanted thoughts. It's more related to <strong>possession</strong> than the form of thought.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Delusion:</strong> It is a false belief that is unshakeable and cannot be explained on the basis of a person's social and cultural background.It is a disorder of <strong>thought content</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Thought insertion:</strong> It is the belief that certain of one's thoughts are not one's own, but rather are inserted into one's mind. This is also a <strong>possession</strong> of thought, not its form.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Formal thought disorders pertain to abnormalities in the organization, associations and connections of the thought. Derailment, loose associations, neologisms are examples of a formal thought disorder.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Kaplan and Sadock’s Synopsis of Psychiatry, 12th edition, Page No 10</strong></span></p>",
      "correct_choice_id": 24586,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74871,
      "choices": [
        {
          "id": 298385,
          "text": "<p><span style=\"font-size:16px;\">Check visual acuity</span></p>"
        },
        {
          "id": 298386,
          "text": "<p><span style=\"font-size:16px;\">Take history</span></p>"
        },
        {
          "id": 298387,
          "text": "<p><span style=\"font-size:16px;\">Intraocular pressure measurement</span></p>"
        },
        {
          "id": 298388,
          "text": "<p><span style=\"font-size:16px;\">Copious irrigation with saline</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">In case of a chemical injury to the eye, what is the immediate first step in the management? (INICET NOV 2024)</span></p>",
      "unique_key": "Q7906811",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682101,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Copious irrigation with saline</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong>&nbsp;</span></p><p><br><span style=\"font-size:16px;\">In chemical injury to the eye, copious irrigation with saline is the immediate first step in management. The primary goal is to remove the offending agent as quickly as possible to minimize tissue damage. Irrigation should be started immediately using whatever solution is available (saline, Ringer's lactate, balanced salt solution, or even plain water). It's crucial not to use neutralizing solutions (like acid for alkali or vice versa) as this can generate heat and cause additional damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:16px;\"><strong>Option A. Check visual acuity</strong>: This is incorrect as checking visual acuity would delay the urgent need to remove the causative chemical agent. Visual acuity can be checked after initial irrigation.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Take history</strong>: This is incorrect. While history is important, it should not delay immediate irrigation. Basic history (type of chemical) can be taken while performing irrigation.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Intraocular pressure measurement</strong>: This is incorrect. IOP measurement has no role in immediate management of chemical injury and could potentially cause more harm if done before thorough irrigation.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p><br><span style=\"font-size:16px;\">Immediate copious irrigation with saline or any available appropriate solution is the first step in managing chemical injury to the eye, taking precedence over all other examinations or investigations.</span></p>",
      "correct_choice_id": 298388,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56095,
      "choices": [
        {
          "id": 223805,
          "text": "<p><span style=\"font-size:12.0pt;\">Lorazepam</span></p>"
        },
        {
          "id": 223806,
          "text": "<p><span style=\"font-size:12.0pt;\">Fomepizole</span></p>"
        },
        {
          "id": 223807,
          "text": "<p><span style=\"font-size:12.0pt;\">Naltrexone</span></p>"
        },
        {
          "id": 223808,
          "text": "<p><span style=\"font-size:12.0pt;\">Buspirone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which drug would be most effective in preventing withdrawal symptoms in a patient with a history of alcohol consumption who was admitted to the hospital after a road traffic accident? (NEET PG 2024)</span></p>",
      "unique_key": "Q5069211",
      "question_audio": null,
      "question_video": null,
      "map_id": 32705189,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Lorazepam</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lorazepam is a benzodiazepine commonly used to manage alcohol withdrawal symptoms. Alcohol withdrawal can present with symptoms like anxiety, tremors, seizures, and delirium tremens, which can be life-threatening. Benzodiazepines, such as lorazepam, work by enhancing the effect of the neurotransmitter GABA, which has a calming effect on the nervous system, thereby reducing the risk of withdrawal symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Fomepizole</strong>: This drug is an alcohol dehydrogenase inhibitor used primarily in the <strong>treatment of methanol and ethylene glycol poisoning</strong>, not for managing alcohol withdrawal symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Naltrexone</strong>: Naltrexone is an opioid receptor antagonist used to reduce cravings and <strong>prevent relapse in patients recovering from alcohol or opioid dependence</strong>. It is not used to manage acute withdrawal symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Buspirone</strong>: Buspirone is an anxiolytic used for the <strong>management of generalized anxiety disorder (GAD</strong>). It is not effective for treating alcohol withdrawal symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Benzodiazepines, such as lorazepam, are the drugs of choice to prevent and manage alcohol withdrawal symptoms.</span></p>",
      "correct_choice_id": 223805,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24715,
      "choices": [
        {
          "id": 98821,
          "text": "<p><span style=\"font-size:12.0pt;\">Voglibose</span></p>"
        },
        {
          "id": 98822,
          "text": "<p><span style=\"font-size:12.0pt;\">Alogliptin</span></p>"
        },
        {
          "id": 98823,
          "text": "<p><span style=\"font-size:12.0pt;\">Pramlintide</span></p>"
        },
        {
          "id": 98824,
          "text": "<p><span style=\"font-size:12.0pt;\">Liraglutide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 52-year-old female with diabetes mellitus has experienced a decrease in her HbA1c levels from 7.6 to 6.7 after starting a new oral medication. Laboratory tests show that she has high levels of GIP and GLP-1 and low levels of glucagon. Which of the following oral drugs was most likely administered to this patient?&nbsp;</span>(INICET MAY 2023)</p>",
      "unique_key": "Q2702561",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682130,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Alogliptin.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Alogliptin is a DPP-4 inhibitor, an oral class of drugs used in the treatment of diabetes. DPP-4 inhibitors work by preventing the breakdown of GLP-1, thereby increasing the levels of GLP-1 in the body, which in turn enhances insulin secretion, reduces glucagon secretion, and slows gastric emptying.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Voglibose</strong>: Voglibose is an alpha-glucosidase inhibitor that delays the absorption of carbohydrates in the intestines. It does not directly affect the levels of incretin hormones like GLP-1 and GIP, nor does it significantly influence glucagon levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Pramlintide</strong>: Pramlintide is an amylin analogue that is used to help control blood sugar levels. It is typically administered by injection and does not significantly increase GLP-1 or GIP levels. It works by slowing gastric emptying and suppressing glucagon secretion, but it does not match the profile described in the question as closely as alogliptin.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Liraglutide</strong>: Liraglutide is a GLP-1 agonist, which would indeed lead to increased GLP-1 levels and decreased glucagon levels. However, liraglutide is administered by injection and not orally. This makes it less likely to be the medication described in the scenario, which specifies an oral drug.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Alogliptin, a DPP-4 inhibitor, is the most likely drug responsible for the increase in GLP-1 and GIP levels and the decrease in glucagon levels in this patient. It effectively lowers HbA1c levels and is administered orally, fitting the description provided.</span></p>",
      "correct_choice_id": 98822,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11830,
      "choices": [
        {
          "id": 47286,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 only</span></span></p>"
        },
        {
          "id": 47287,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2 and 3</span></span></p>"
        },
        {
          "id": 47288,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2, 3 and 4</span></span></p>"
        },
        {
          "id": 47289,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 2, 3 and 4</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 60-year-old male patient with critical mitral stenosis presented with atrial fibrillation. He has a history of multiple episodes of transient ischemic attacks. Which of the following are true regarding the prevention of stroke in this patient? (INICET NOV 2021)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Only aspirin is given</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Warfarin is given</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Direct oral anticoagulants are not indicated</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mitral valvotomy should be recommended</span></span></span></li>\r\n</ol>",
      "unique_key": "Q6646539",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682111,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) 2 and 3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For a patient with critical mitral stenosis and atrial fibrillation, particularly one with a history of transient ischemic attacks (TIA), anticoagulation therapy is essential. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">2. Warfarin is the preferred anticoagulant in cases of severe mitral stenosis due to its proven effectiveness in preventing thromboembolic events. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">3. Direct oral anticoagulants (DOACs) are not recommended in this scenario as they are not indicated for patients with moderate to severe mitral stenosis. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1. Aspirin alone is insufficient to prevent stroke in this context. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">4. Mitral valvotomy is not recommended at this point because performing the procedure could dislodge existing clots, leading to embolic events.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In patients with critical mitral stenosis and atrial fibrillation, especially those with a history of TIA, Warfarin should be given for stroke prevention, and direct oral anticoagulants are not indicated.</span></span></span></p>",
      "correct_choice_id": 47287,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54330,
      "choices": [
        {
          "id": 216789,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gonadal Dyagenesis </span></span></span></p>"
        },
        {
          "id": 216790,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mullerian Agenesis </span></span></span></p>"
        },
        {
          "id": 216791,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Kallman Syndrome</span></span></span></p>"
        },
        {
          "id": 216792,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Androgen insensitivity Syndrome</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">16-year-old girl presented with primary amenorrhea. On examination she has well developed secondary sexual characters and labs revealed a normal LH and FSH. Her karyotype is 46XX. What is the likely diagnosis?</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q2545211",
      "question_audio": null,
      "question_video": null,
      "map_id": 32705482,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Mullerian Agenesis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mullerian agenesis, also known as Mayer-Rokitansky-K&uuml;ster-Hauser (MRKH) syndrome, is the most likely diagnosis for this patient. The key features supporting this diagnosis are:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Primary amenorrhea in a 16-year-old girl</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Well-developed secondary sexual characters</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Normal LH and FSH levels</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">46,XX karyotype</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In Mullerian agenesis, the uterus and upper vagina fail to develop properly, but the ovaries function normally. This explains the presence of secondary sexual characteristics and normal hormone levels, despite the absence of menstruation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Gonadal Dyagenesis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Incorrect because patients with gonadal dysgenesis typically have high FSH and LH levels due to lack of negative feedback from functioning gonads. They also often lack secondary sexual characteristics.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Kallmann Syndrome:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Incorrect</span><span style=\"font-size:12.0pt\">, isolated GnRH deficiency which </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">is characterized by</span> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">low LH and FSH levels, absent secondary sexual characteristics, and often associated with anosmia (loss of smell). The patient in this case has normal hormone levels and well-developed secondary sexual characteristics.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Androgen Insensitivity Syndrome</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Incorrect because this condition has a 46,XY karyotype, not 46,XX as in this case. Additionally, individuals with complete AIS would present with female external genitalia but lack a uterus and ovaries.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mullerian agenesis (MRKH syndrome) presents with primary amenorrhea, normal secondary sexual characteristics, normal hormone levels (LH and FSH), and a 46,XX karyotype.</span></span></p>",
      "correct_choice_id": 216790,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11461,
      "choices": [
        {
          "id": 45810,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Right atrial contraction</span></span></span></span></p>"
        },
        {
          "id": 45811,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Closure of tricuspid valve</span></span></span></span></p>"
        },
        {
          "id": 45812,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Onset of ventricular systole</span></span></span></span></p>"
        },
        {
          "id": 45813,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maximal atrial filling</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&#39;a&#39; wave in JVP corresponds to? (AIIMS MAY 2018)</span></span></p>",
      "unique_key": "Q4350867",
      "question_audio": null,
      "question_video": null,
      "map_id": 32705483,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Right atrial contraction</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The &#39;a&#39; wave in the jugular venous pulse (JVP) represents right atrial contraction. This occurs towards the end of ventricular diastole and reflects the pressure increase within the right atrium as it contracts to push blood into the right ventricle just before the tricuspid valve closes.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Closure of tricuspid valve:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect, this would not be specifically represented by an &#39;a&#39; wave; instead, it typically follows the &#39;a&#39; wave and leads into the &#39;c&#39; wave associated with right ventricular contraction.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Onset of ventricular systole:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect, ventricular systole corresponds to the &#39;c&#39; wave and the &#39;x&#39; descent on JVP.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Maximal atrial filling:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect, maximal atrial filling occurs towards the end of the &#39;v&#39; wave and into the &#39;y&#39; descent, which corresponds to passive ventricular filling when the tricuspid valve is open.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture56.jpg\" style=\"height:517px; width:1000px\" /></span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Harrison/Cardiology/Basics of CVS/Chap 239</span></span></strong></span></span></p>",
      "correct_choice_id": 45810,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60486,
      "choices": [
        {
          "id": 241237,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Systolic BP &lt;90 mmHg</span></span></p>"
        },
        {
          "id": 241238,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Temperature &gt;38 degrees Celsius or &lt;36 degrees Celsius</span></span></p>"
        },
        {
          "id": 241239,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Respiratory rate &gt;20 bpm</span></span></p>"
        },
        {
          "id": 241240,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Heart rate &gt;90/min</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All the following are criteria for SIRS, except ______. (INICET NOV 2022)<span style=\"color:#00b050\"> </span></span></span></p>",
      "unique_key": "Q6775003",
      "question_audio": null,
      "question_video": null,
      "map_id": 32705485,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Systolic BP &lt;90 mmHg </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Systolic BP &lt;90 mmHg</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">not</span></strong> a criterion for <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SIRS</span></strong> (Systemic Inflammatory Response Syndrome).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SIRS is diagnosed when <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">two</span></strong> of the following criteria are present:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperthermia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (&gt;38&deg;C) or <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">hypothermia</span></strong> (&lt;36&deg;C)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tachypnea</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (respiratory rate &gt;20 breaths per minute) or arterial carbon dioxide tension (PaCO₂) &lt;32 mmHg</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tachycardia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (heart rate &gt;90 beats per minute)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">White blood cell count &gt;12 &times; 10⁹/L or &lt;4 &times; 10⁹/L, or &gt;10% band forms (immature neutrophils)</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sepsis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is SIRS with a documented infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Temperature &gt;38&deg;C or &lt;36&deg;C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Is a part of the SIRS criteria.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Respiratory rate &gt;20 breaths/min:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Is a criterion for SIRS (tachypnea).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Heart rate &gt;90/min:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (tachycardia) is also one of the criteria for SIRS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SIRS criteria include hyperthermia/hypothermia, tachycardia, tachypnea, and abnormal white blood cell count. Systolic BP is <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">not</span></strong> included as a direct diagnostic criterion for SIRS.</span></span></span></p>",
      "correct_choice_id": 241237,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76134,
      "choices": [
        {
          "id": 303409,
          "text": "<p><span style=\"font-size:18px;\">Analysis, Blinding, Inclusion and Exclusion, Randomization</span></p>"
        },
        {
          "id": 303410,
          "text": "<p><span style=\"font-size:18px;\">Blinding, Inclusion and Exclusion, Randomization, Analysis,&nbsp;</span></p>"
        },
        {
          "id": 303411,
          "text": "<p><span style=\"font-size:18px;\">Inclusion and Exclusion, Randomization, Blinding, Analysis</span></p>"
        },
        {
          "id": 303412,
          "text": "<p><span style=\"font-size:18px;\">Inclusion and Exclusion, Blinding, Randomization, Analysis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>Among the following, mark the correct sequence of steps for a Randomized controlled trial (RCT)?</strong><i><strong> [INICET NOV 2024]</strong></i></span></p>",
      "unique_key": "Q2158374",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682112,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Inclusion and Exclusion, Randomization, Blinding, Analysis</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The correct sequence for the steps of a Randomized Controlled Trial (RCT) is first defining the <strong>inclusion and exclusion criteria, then randomization, followed by blinding, and finally analysis of results.&nbsp;</strong></span></li><li><span style=\"font-size:18px;\">This sequence follows the logical flow of conducting an RCT.</span></li><li><span style=\"font-size:18px;\">RCT protocol includes first making a protocol that defines aims, objectives, and hypothesis.&nbsp;</span></li><li><span style=\"font-size:18px;\">Then the steps proceed as:&nbsp;</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:18px;\"><strong>Defining the target population</strong></span></li><li><span style=\"font-size:18px;\"><strong>Making inclusion and exclusion</strong> <strong>criteria</strong></span></li><li><span style=\"font-size:18px;\"><strong>Randomization</strong></span></li><li><span style=\"font-size:18px;\"><strong>Blinding of intervention&nbsp;</strong></span></li><li><span style=\"font-size:18px;\"><strong>Analysis of results</strong></span></li></ol></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The correct sequence of steps in conducting a Randomized Controlled Trial (RCT): defining <strong>inclusion and exclusion criteria, randomization, blinding, and finally analysis.</strong></span></p>",
      "correct_choice_id": 303411,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5852,
      "choices": [
        {
          "id": 23378,
          "text": "<p><span style=\"font-size:12pt;\">Deceleration</span></p>"
        },
        {
          "id": 23379,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Acceleration</span></p>"
        },
        {
          "id": 23380,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Normal</span></p>"
        },
        {
          "id": 23381,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Deceleration followed by acceleration</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What does this Cardio-Tocography show?&nbsp;</span>&nbsp;(INICET MAY 2019)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/1_LB2EmwO.jpg\" alt=\"\" width=\"300\" height=\"204\"></span></p>",
      "unique_key": "Q3801571",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682122,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Deceleration</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The Cardio-Tocography (CTG) in question shows decelerations, which are characterized by a drop in the fetal heart rate (FHR) by at least 15 beats per minute (bpm) lasting for at least 15 seconds.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Types of Decelerations on CTG:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\"><strong>Early Deceleration:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">The nadir (lowest point) of the deceleration corresponds with the peak of the uterine contraction.</span></li><li><span style=\"font-size:12pt;\">Caused by head compression during contractions.</span></li><li><span style=\"font-size:12pt;\">Commonly observed in the second stage of labor.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Late Deceleration:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">The nadir of the deceleration occurs after the peak of the contraction.</span></li><li><span style=\"font-size:12pt;\">Indicative of uteroplacental insufficiency, which can lead to fetal distress or hypoxia.</span></li><li><span style=\"font-size:12pt;\">Considered an ominous sign and requires prompt evaluation and intervention.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Variable Deceleration:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">There is no fixed relationship between the deceleration and uterine contractions.</span></li><li><span style=\"font-size:12pt;\">Caused by umbilical cord compression, often seen with oligohydramnios.</span></li><li><span style=\"font-size:12pt;\">Significant if persistent, with FHR &lt;70 bpm for more than 60 seconds.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Prolonged Deceleration:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Occurs when the deceleration lasts beyond 2 minutes but less than 10 minutes.</span></li><li><span style=\"font-size:12pt;\">May indicate acute fetal hypoxia, such as with cord prolapse or intrapartum abruption.</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Acceleration:</strong> This would show an increase in the fetal heart rate by at least 15 bpm lasting for at least 15 seconds, which is not the case here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Normal:</strong> A normal CTG would not show any decelerations or would show a typical pattern of fetal heart rate variability and accelerations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Deceleration followed by acceleration:</strong> This pattern would indicate a combination of deceleration and acceleration, which is not specified here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Decelerations on a Cardio-Tocography indicate a decrease in fetal heart rate by at least 15 bpm lasting for at least 15 seconds, with different types signifying various conditions and levels of concern.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 994, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23378,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5849,
      "choices": [
        {
          "id": 23366,
          "text": "<p><span style=\"font-size:12pt;\">Amniocentesis at 16 weeks</span></p>"
        },
        {
          "id": 23367,
          "text": "<p><span style=\"font-size:12pt;\">Manual removal of placenta</span></p>"
        },
        {
          "id": 23368,
          "text": "<p><span style=\"font-size:12pt;\">Intrauterine transfusion at 28 weeks</span></p>"
        },
        {
          "id": 23369,
          "text": "<p><span style=\"font-size:12pt;\">MTP at 63 days</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Anti-D vaccine is not given in which of the following conditions?&nbsp;</span>(INICET MAY 2019)</p>",
      "unique_key": "Q8374705",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682099,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Intrauterine transfusion at 28 weeks</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The Anti-D vaccine (anti-D immunoglobulin) is typically administered to prevent Rh sensitization in Rh-negative women who might be exposed to Rh-positive fetal blood. It is given to protect against the formation of anti-Rh antibodies that could affect future pregnancies. The vaccine is not given after an intrauterine transfusion because this procedure is performed to treat severe fetal anemia in cases where the mother is Rh-positive or the indirect Coombs test (ICT) is positive, indicating that the mother has already been sensitized.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Amniocentesis at 16 weeks:</strong> Anti-D vaccine is given after amniocentesis to prevent Rh sensitization, as the procedure can cause fetal blood to mix with maternal blood.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Manual removal of placenta:</strong> Anti-D vaccine is administered after manual removal of the placenta to prevent sensitization, as this procedure can result in significant feto-maternal hemorrhage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. MTP at 63 days:</strong> Anti-D vaccine is given after medical termination of pregnancy (MTP) to prevent Rh sensitization if the mother is Rh-negative and the fetus is Rh-positive.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Anti-D vaccine is not given after intrauterine transfusion, as this procedure is used to treat severe fetal anemia and does not require further prophylaxis against Rh sensitization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 919, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23368,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11044,
      "choices": [
        {
          "id": 44142,
          "text": "<p><span style=\"font-size:18px;\">Azithromycin + Metronidazole</span></p>"
        },
        {
          "id": 44143,
          "text": "<p><span style=\"font-size:18px;\">Cefixime + Azithromycin</span></p>"
        },
        {
          "id": 44144,
          "text": "<p><span style=\"font-size:18px;\">Azithromycin + Doxycycline</span></p>"
        },
        {
          "id": 44145,
          "text": "<p><span style=\"font-size:18px;\">Doxycycline + Cefixime</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>Dr. Rajan is a consultant at a primary health center, frequently encountering cases of sexually transmitted infections (STIs) and reproductive tract infections (RTIs). He usually prefers syndromic approach for managing these conditions due to limited diagnostic facilities. A 28-year-old male patient walks in, presenting with discharge from his urethra, indicating a possible urethritis. The patient is unaware of the specific causative organism. Given the syndromic management approach, which combination of medications would Dr. Rajan most likely prescribe to effectively treat both gonococcal and non-gonococcal urethritis? </strong><i><strong>[AIIMS MAY 2017]</strong></i></span></p>",
      "unique_key": "Q5084789",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682132,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) Cefixime + Azithromycin</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">&nbsp;According to the syndromic approach for managing STIs/RTIs, the preferred treatment for both gonococcal and non-gonococcal urethritis involves a combination of Azithromycin and Cefixime.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-114908.png\" alt=\"\" width=\"1000\" height=\"514\"></span></p>",
      "correct_choice_id": 44143,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56094,
      "choices": [
        {
          "id": 223801,
          "text": "<p><span style=\"font-size:12.0pt;\">Treat with aversive therapy</span></p>"
        },
        {
          "id": 223802,
          "text": "<p><span style=\"font-size:12.0pt;\">Treat with behavioral therapy</span></p>"
        },
        {
          "id": 223803,
          "text": "<p><span style=\"font-size:12.0pt;\">Valproate</span></p>"
        },
        {
          "id": 223804,
          "text": "<p><span style=\"font-size:12.0pt;\">Ketogenic diet</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young girl presented with a history of multiple episodes of loss of consciousness that lasted for 5-10 minutes. These episodes occur only in front of family members and only in the daytime. The patient can recall the conversation that happened around her during these episodes; there is no history of tongue bite and no incontinence. What is the preferred treatment? (NEET PG 2024)</span></p>",
      "unique_key": "Q3644245",
      "question_audio": null,
      "question_video": null,
      "map_id": 32705190,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Treat with behavioral therapy</strong></span></p><p><span style=\"font-size:11pt;\"><strong>&nbsp;&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\">The patient's symptoms—episodes of apparent loss of consciousness only occurring in front of family members, during the day, with the ability to recall surrounding conversations—suggest that these are not true seizures but <strong>pseudoseizures,</strong> which are commonly associated with <strong>conversion disorder</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Conversion disorder is characterized by neurological symptoms without a medical or neurological cause, often triggered by psychological factors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Behavioral therapy is the preferred treatment for conversion disorder. This approach helps the patient address and modify the underlying psychological factors contributing to their symptoms through techniques such as cognitive restructuring, relaxation techniques, and coping strategies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Treat with aversive therapy:&nbsp;</strong>Aversive therapy involves applying unpleasant stimuli to reduce the occurrence of undesirable behaviors. It is considered unethical, especially in treating psychological disorders like conversion disorder, because it can cause harm and does not address the underlying psychological issues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Valproate:&nbsp;</strong>Valproate is an antiepileptic medication used to treat true seizures, but it is not appropriate for conversion disorder or pseudoseizures since the condition is psychological rather than neurological.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp; Ketogenic diet:&nbsp;</strong>The ketogenic diet is sometimes used to manage epilepsy but is not suitable for conversion disorder. The diet has no role in addressing psychological origins of symptoms like pseudoseizures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The preferred treatment for conversion disorder, which manifests with pseudoseizures, is behavioral therapy, not antiepileptic drugs or other seizure management strategies.</span></p>",
      "correct_choice_id": 223802,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 74870,
      "choices": [
        {
          "id": 298381,
          "text": "<p><span style=\"font-size:16px;\">Electrooculogram (EOG)</span></p>"
        },
        {
          "id": 298382,
          "text": "<p><span style=\"font-size:16px;\">Electroretinogram (ERG)</span></p>"
        },
        {
          "id": 298383,
          "text": "<p><span style=\"font-size:16px;\">Visual Evoked potential&nbsp;</span></p>"
        },
        {
          "id": 298384,
          "text": "<p><span style=\"font-size:16px;\">Multifocal electro retinogram&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which is the investigation of choice for Best disease? (INICET NOV 2024)</span></p>",
      "unique_key": "Q6338425",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682109,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Electrooculogram (EOG)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong>&nbsp;</span></p><p><br><span style=\"font-size:16px;\">Electrooculogram (EOG) is the investigation of choice for Best disease. EOG is the only condition where best disease has significant diagnostic value, and Best disease is the only condition where EOG is of primary diagnostic significance. In Best disease, the Arden ratio (peak to trough ratio) in EOG is abnormal (&lt;1.5) while ERG remains normal in early stages. EOG measures the standing potential between the front and back of the eye and is particularly sensitive to RPE function, which is primarily affected in Best disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong>&nbsp;</span></p><p><br><span style=\"font-size:16px;\"><strong>Option B. Electroretinogram (ERG)</strong>:This is incorrect because ERG is typically normal in Best disease, especially in early stages. ERG measures the electrical response of the retina to light stimulation and primarily tests photoreceptor function.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Visual Evoked potential</strong>: This is incorrect because VEP tests the integrity of the entire visual pathway from retina to occipital cortex and is not specific for Best disease. It records the electrical activity in the visual cortex in response to visual stimuli.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Multifocal electro retinogram</strong>: This is incorrect because mfERG, while useful for evaluating macular function, is not the primary diagnostic test for Best disease. It provides topographic measurement of retinal electrophysiological activity in the central retina.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p><br><span style=\"font-size:16px;\">Electrooculogram (EOG) is the investigation of choice for Best disease, with an abnormal Arden ratio (&lt;1.5) being diagnostic while ERG remains normal in early stages.</span></p>",
      "correct_choice_id": 298381,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6707,
      "choices": [
        {
          "id": 26797,
          "text": "<p><span style=\"font-size:12.0pt;\">A-4, B-2, C-3, D-1</span></p>"
        },
        {
          "id": 26798,
          "text": "<p><span style=\"font-size:12.0pt;\">A-3, B-4, C-1, D-2</span></p>"
        },
        {
          "id": 26799,
          "text": "<p><span style=\"font-size:12.0pt;\">A-1, B-4, C-2, D-3</span></p>"
        },
        {
          "id": 26800,
          "text": "<p><span style=\"font-size:12.0pt;\">A-2, B-4, C-1, D-3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following? (</span>INICET Nov 2021)</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/12/screenshot-2023-10-12-164243.jpg\" alt=\"\" width=\"700\" height=\"311\"></span></p>",
      "unique_key": "Q8232933",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682120,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) A-2, B-4, C-1, D-3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Twilight (A)&nbsp;</strong>refers to a transient, impaired state of consciousness often seen during seizures or certain other medical conditions. Therefore, it matches with <strong>Impaired level of consciousness (2).</strong></span></p><p><span style=\"font-size:10.5pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Oneroid state (B)&nbsp;</strong>is a term used in psychiatry to describe a dream-like state of consciousness, hence matching with <strong>Oneirophrenia (4)</strong>, which is derived from the words meaning 'dream' and 'mind'.</span></p><p><span style=\"font-size:10.5pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Oligophrenia (C)&nbsp;</strong>is an outdated medical term used to describe intellectual disability or subnormal intelligence. Thus, it matches with <strong>Subnormal intelligence (1)</strong>.</span></p><p><span style=\"font-size:10.5pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Paranoid Ideation (D)&nbsp;</strong>involves thoughts dominated by ideas of persecution or conspiracy against the individual. This matches with <strong>Persecution (3)</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Oneroid state is characterized by a dream-like state resembling Oneirophrenia. Oligophrenia refers to intellectual disability, and Paranoid Ideation is centered on ideas of persecution.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Sim’s symptoms in the Mind, 7th edition, Page No 39, 40, 132; Kaplan &amp; Sadock’s Comprehensive Textbook of Psychiatry, 10th edition, Page No 4599.</strong></span></p>",
      "correct_choice_id": 26800,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11517,
      "choices": [
        {
          "id": 46034,
          "text": "<p><span style=\"font-size:12.0pt;\">Posterior inferior cerebellar artery</span></p>"
        },
        {
          "id": 46035,
          "text": "<p><span style=\"font-size:12.0pt;\">Anterior inferior cerebellar artery</span></p>"
        },
        {
          "id": 46036,
          "text": "<p><span style=\"font-size:12.0pt;\">Superior cerebellar artery</span></p>"
        },
        {
          "id": 46037,
          "text": "<p><span style=\"font-size:12.0pt;\">Basilar artery</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient presents with vertigo, diplopia, hoarseness, dysphagia and left Horner's syndrome associated with numbness of the left face and right-side limbs. Which artery is affected in this patient? (AIIMS MAY 2020)</span></p>",
      "unique_key": "Q3951674",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682121,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A)&nbsp;Posterior inferior cerebellar artery</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clinical features are suggestive of Lateral Medullary syndrome/Wallenburg syndrome which occurs due to PICA occlusion. His syndrome is characterized by a range of neurological deficits due to ischemia in the lateral part of the medulla oblongata, where PICA provides blood supply.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Clinical Features Associated with PICA Occlusion:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Vertigo and Diplopia:&nbsp;</strong>Caused by the involvement of the vestibular nuclei and adjacent structures.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Hoarseness and Dysphagia:&nbsp;</strong>Result from damage to the nucleus ambiguous, affecting the vagal and glossopharyngeal nerve functions.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Horner’s Syndrome:&nbsp;</strong>Occurs due to disruption of the sympathetic pathways.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Numbness of the Face and Contralateral Limbs:&nbsp;</strong>Caused by damage to the spinal trigeminal nucleus and the spinothalamic tract, respectively.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Anterior Inferior Cerebellar Artery (AICA):&nbsp;</strong>Affects a similar region but typically presents with symptoms like hearing loss due to its supply to the inner ear structures, which is not mentioned in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Superior Cerebellar Artery:&nbsp;</strong>Occlusion typically results in ataxia and coordination difficulties without the cross-sensory loss observed in Wallenberg's Syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Basilar Artery:&nbsp;</strong>A much broader array of symptoms would be expected, potentially affecting multiple cranial nerve and long tract functions simultaneously.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Image: Arteries involved in brainstem syndromes lateral vs medial brainstem</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture41.jpg\" alt=\"\" width=\"500\" height=\"493\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture42.jpg\" alt=\"\" width=\"1000\" height=\"249\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21E/Chap 426, </strong><i><strong>Neurology/stroke</strong></i></span></p>",
      "correct_choice_id": 46034,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24604,
      "choices": [
        {
          "id": 98377,
          "text": "<p><span style=\"font-size:12.0pt;\">Water in stomach</span></p>"
        },
        {
          "id": 98378,
          "text": "<p><span style=\"font-size:12.0pt;\">Washerwoman's hands and feet</span></p>"
        },
        {
          "id": 98379,
          "text": "<p><span style=\"font-size:12.0pt;\">White leathery foam around mouth and nostrils</span></p>"
        },
        {
          "id": 98380,
          "text": "<p><span style=\"font-size:12.0pt;\">Positive diatom test</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">An autopsy was performed on a woman who was reportedly discovered near a village lake. Among the listed factors, which one does not indicate drowning prior to death:(INICET MAY 2023)</span></p>",
      "unique_key": "Q6388409",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682116,
      "difficulty_level": "intermediate",
      "subjects_id": [
        10
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Washerwoman's hands and feet</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Washerwoman's hands and feet just indicates that body was immersed in water. It does not specify whether the person died due to drowning or not. It occurs due to infiltration of water into the outer layers of the skin, which will occur irrespective whether the person died due to drowning or the body was thrown in water after death.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/10/screenshot-2024-06-10-095140.png\" alt=\"\" width=\"300\" height=\"199\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">If a body is recovered from water, the there are two different kind of signs to look for:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Signs of Antemortem Drowning:&nbsp;</strong>These will indicate that person died due to drowning.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Signs of Immersion:&nbsp;</strong>These will only indicate that the body was in water.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Signs of Antemortem Drowning (in descending order of accuracy):</u></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Grass or weeds tightly held in hands (cadaveric Spasm): Surest sign</span></li><li><span style=\"font-size:12.0pt;\">Drowning Froth Over Mouth and Nose and in air passages: Second best sign</span></li><li><span style=\"font-size:12.0pt;\">Emphysema Aquosum (overinflated lungs)</span></li><li><span style=\"font-size:12.0pt;\">Presence of sand / mud etc. in respiratory passages especially in terminal part</span></li><li><span style=\"font-size:12.0pt;\">Diatom test</span></li><li><span style=\"font-size:12.0pt;\">Presence of water especially if mixed with mud / sand etc. in Stomach or intestines</span></li><li><span style=\"font-size:12.0pt;\">Paltauff Haemorrhage (Subpleural Haemorrhage)</span></li><li><span style=\"font-size:12.0pt;\">Gettler’s test</span></li></ul><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Signs of Immersion</u></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Washerwoman’s hand / feet</span></li><li><span style=\"font-size:12.0pt;\">Cutis anserina=goose skin</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Water in stomach:</strong> This suggests that the person was alive when entering the water and swallowed water, indicating antemortem drowning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. White leathery foam around mouth and nostrils:</strong> This foam, often referred to as \"drowning froth,\" is a strong indicator of antemortem drowning as it forms when water mixes with air and mucus in the airways.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Positive diatom test:</strong> The presence of diatoms in the organs indicates that the person inhaled water while still alive, allowing these microscopic algae to enter the bloodstream and be deposited in various tissues, thus confirming antemortem drowning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Washerwoman's hands and feet indicate immersion in water but do not specify drowning as the cause of death, unlike other indicators such as water in the stomach, white leathery foam, and a positive diatom test, which strongly suggest antemortem drowning.</span></p>",
      "correct_choice_id": 98378,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7153,
      "choices": [
        {
          "id": 28580,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This action can be reversed by phenylephrine.</span></span></span></span></span></p>"
        },
        {
          "id": 28581,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿It cannot be reversed by levallorphan.</span></span></span></span></span></p>"
        },
        {
          "id": 28582,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\">﻿﻿﻿<span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is caused by activation of the Edinger-Westphal nucleus.</span></span></span></span></span></p>"
        },
        {
          "id": 28583,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Tolerance develops to this adverse effect on long-term use.</span></span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with a history of substance addiction is admitted to the hospital due to the overdose of the addictive substance. The patient has slow heart rate, respiratory depression, and low blood pressure. His ocular findings are shown below. Which of the following statements is true regarding this condition? (INICET NOV 2022)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/750.jpg\" style=\"height:202px; width:300px\" /></span></span></span></span></span></p>",
      "unique_key": "Q2276188",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682097,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C.<span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> It is caused by activation of the Edinger-Westphal nucleus.</span></strong></span></span></span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The pupil is constricted in the given image and as the history describes the patient to be an addict, who is brought to the hospital in an intoxicated state. The clinical features like pin-point pupils, bradycardia, hypotension, respiratory depression suggests that this is a case of opioid intoxication.</span></span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Opioid induced miosis:</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The pupillary constriction caused by opioids result due to the activation of the Edinger Westphal Nucleus. Therefore, topical use of opioids in the eye does not induce miosis. It will be seen only on systemic administration of opioids. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The miosis induced by opioids cannot be reversed by mydriatic drugs like phenylephrine or anticholinergic drugs. Rather it can be reversed by opioid antagonists like naloxone and levallorphan.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tolerance does not develop to opioid induced miosis even on long term use. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A. This action can be reversed by phenylephrine</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Phenylephrine is a mydriatic agent that causes dilation of the pupil by stimulating alpha-1 adrenergic receptors. It would not reverse opioid-induced miosis, which is due to central nervous system effects rather than direct effects on the iris muscles.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. It cannot be reversed by levallorphan</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Levallorphan is an opioid antagonist that can reverse the effects of opioid toxicity, including miosis. Therefore, this statement is incorrect.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. Tolerance develops to this adverse effect on long-term use:</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Tolerance to opioid-induced miosis does not typically develop, even with long-term use of opioids. Therefore, this statement is incorrect.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Opioid-induced miosis is caused by activation of the Edinger-Westphal nucleus, and it is a characteristic sign of opioid intoxication. This effect cannot be reversed by phenylephrine, and tolerance does not develop to this effect with long-term opioid use. Opioid antagonists like naloxone and levallorphan can reverse the miosis caused by opioid overdose</span></span></span></p>",
      "correct_choice_id": 28582,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13081,
      "choices": [
        {
          "id": 52286,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2 and 3</span></p>"
        },
        {
          "id": 52287,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 2</span></p>"
        },
        {
          "id": 52288,
          "text": "<p><span style=\"font-size:12.0pt;\">2 and 3</span></p>"
        },
        {
          "id": 52289,
          "text": "<p><span style=\"font-size:12.0pt;\">3 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 27-year-old female patient presents with complaint of sudden diminishing vision. On examination, relative afferent pupillary defect is noted in the right eye and the left eye is normal. Which of the following investigations would you do next? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET May 2022)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">MRI brain and orbit</span></li><li><span style=\"font-size:12.0pt;\">Myelin oligodendrocyte oligoprotein (MOG) and neuromyelitis optica (NMO) antibodies</span></li><li><span style=\"font-size:12.0pt;\">Blood sugar</span></li><li><span style=\"font-size:12.0pt;\">Thyroid profile</span></li></ol>",
      "unique_key": "Q6969710",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682103,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 1, 2 and 3</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The presented clinical features suggest optic neuritis, which is characterized by sudden, progressive, and profound visual loss along with relative afferent pupillary defect (RAPD).</span></li><li><span style=\"font-size:12.0pt;\">The recommended investigations for optic neuritis include MRI brain and orbit, screening for circulating MOG and NMO antibodies, and checking blood sugar levels.</span></li><li><span style=\"font-size:12.0pt;\">Brain MRI is suggested in every patient after the first attack of optic neuritis, as there is a high probability of developing multiple sclerosis.</span></li><li><span style=\"font-size:12.0pt;\">Neuromyelitis optica (NMO) is a severe type of optic neuritis that can occur bilaterally and is associated with myelitis. The presence of MOG and MO antibodies can diagnose the condition.</span></li><li><span style=\"font-size:12.0pt;\">Reason for checking blood glucose level-</span><ul><li><span style=\"font-size:12.0pt;\">If it turns out to be optic neuritis, blood glucose levels should be measured as steroids are mainstay treatment modality</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Marcus Gunn pupil, which indicates RAPD, is a characteristic sign of optic neuritis. It is elicited by the swinging flashlight test, where the eyes' response to light is observed by swinging the flashlight multiple times.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Thyroid profile:&nbsp;</strong>This<strong> </strong>is generally not directly relevant to acute visual changes associated with optic neuritis unless there is a suspicion of thyroid eye disease, which typically presents with other distinctive signs such as exophthalmos, eyelid retraction, and ophthalmoplegia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cases of sudden visual loss with RAPD, it is crucial to perform a thorough diagnostic evaluation to determine the underlying cause. MRI of the brain and orbits, along with specific antibody tests for MOG and NMO, provide critical information for accurate diagnosis and appropriate management of optic neuritis and related conditions. Monitoring blood sugar levels is also essential, especially in the context of potential steroid therapy.</span></p>",
      "correct_choice_id": 52286,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2048,
      "choices": [
        {
          "id": 8185,
          "text": "<p><span style=\"font-size:12.0pt;\">B12</span></p>"
        },
        {
          "id": 8186,
          "text": "<p><span style=\"font-size:12.0pt;\">B6</span></p>"
        },
        {
          "id": 8187,
          "text": "<p><span style=\"font-size:12.0pt;\">Folate</span></p>"
        },
        {
          "id": 8188,
          "text": "<p><span style=\"font-size:12.0pt;\">Vit E</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Uracil was found in genetic code. Which vitamin deficiency leads to this condition:</span>(INICET May 2022)</p>",
      "unique_key": "Q6226926",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682162,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Folate</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Folate deficiency is the correct answer. Folate (also known as vitamin B9) plays a crucial role in DNA synthesis and repair. When there is a deficiency in folate, it can lead to the misincorporation of Uracil into DNA, causing DNA instability and other genetic abnormalities.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. B12: </strong>A deficiency in vitamin B12 is not directly associated with the presence of Uracil in the genetic code. Vitamin B12 deficiency primarily affects red blood cell production and neurological functions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. B6: </strong>A deficiency in vitamin B6 is also not directly related to the presence of Uracil in the genetic code. Vitamin B6 deficiency can lead to various neurological symptoms but does not cause Uracil incorporation into DNA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Vit E: </strong>Vitamin E deficiency does not lead to the presence of Uracil in the genetic code. Vitamin E is primarily known for its antioxidant properties and its role in maintaining cell membranes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Genetic code is related to DNA, but DNA do not contain Uracil. In pyrimidine synthesis, UMP is the first pyrimidine nucleotide to be synthesized and other two pyrimidines thymine and Cytosine are synthesized from it. Uracil to cytosine conversion requires amino group addition provided by glutamine. Uracil is converted to thymine by enzyme thymidylate synthase by methylation where methyl group is donated by methyl-THF. So, a deficiency Folate will result in thymine deficiency and may lead to uracil appearing in the DNA in place of thymine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Harper’s 31<sup>st</sup> ed/pg- 333</strong></span></p>",
      "correct_choice_id": 8187,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56092,
      "choices": [
        {
          "id": 223793,
          "text": "<p><span style=\"font-size:12.0pt;\">Behavioural therapy</span></p>"
        },
        {
          "id": 223794,
          "text": "<p><span style=\"font-size:12.0pt;\">SSRI</span></p>"
        },
        {
          "id": 223795,
          "text": "<p><span style=\"font-size:12.0pt;\">Atypical antipsychotics</span></p>"
        },
        {
          "id": 223796,
          "text": "<p><span style=\"font-size:12.0pt;\">Allow her for surgery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old female, who had visited multiple plastic surgeons requesting correction of \"face deformity,\" was referred to a Psychiatrist. The patient insists that her face is deformed and needs surgery despite no evidence of deformity in the examination. The patient persists with her demand despite family members’ and doctors' reassurances. What is the management? (NEET PG 2024)</span></p>",
      "unique_key": "Q5468418",
      "question_audio": null,
      "question_video": null,
      "map_id": 32705192,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;B) SSRI</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient described in the question is suffering from <strong>Body Dysmorphic Disorder (BDD)</strong>. BDD is a mental health condition characterized by an excessive preoccupation with an imagined defect in appearance, or if a minor physical anomaly is present, the person's concern is markedly excessive. Patients often have poor or absent insight, believing firmly in the existence of their perceived defects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>The standard treatment for BDD includes Selective Serotonin Reuptake Inhibitors (SSRIs) (DOC) and Cognitive Behavioral Therapy (CBT).</strong> Even when a patient's insight is at a delusional level, SSRIs remain the first-line pharmacological treatment, as they help reduce obsessive thoughts and compulsive behaviors associated with the disorder. In this case, SSRIs would be the best management option.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Behavioural therapy:</strong> While behavioral therapy might offer some benefits, the specific first-line treatment for BDD is Cognitive Behavioral Therapy (CBT), which targets the distorted beliefs about appearance directly. The term \"Behavioral Therapy\" is broad and less specific, making SSRIs a more targeted choice.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Atypical antipsychotics:</strong> These medications are not considered first-line treatment for BDD. They may be used as adjuncts in severe cases where delusional beliefs persist despite SSRIs, but they are not the primary treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Allow her for surgery:</strong> Surgery is not a recommended treatment for BDD as it does not address the underlying psychiatric condition and often worsens the patient's mental health state by reinforcing their preoccupation with appearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In Body Dysmorphic Disorder (BDD), especially when insight is poor or absent, SSRIs are the drug of choice for management, often in combination with Cognitive Behavioral Therapy (CBT). Surgery is contraindicated as it does not address the core psychological issue.</span></p>",
      "correct_choice_id": 223794,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5808,
      "choices": [
        {
          "id": 23202,
          "text": "<p><span style=\"font-size:12pt;\">Immediate termination</span></p>"
        },
        {
          "id": 23203,
          "text": "<p><span style=\"font-size:12pt;\">Give surfactant and wait till 36 weeks</span></p>"
        },
        {
          "id": 23204,
          "text": "<p><span style=\"font-size:12pt;\">Do Doppler everyday to check for reversion</span></p>"
        },
        {
          "id": 23205,
          "text": "<p><span style=\"font-size:12pt;\">Terminate after 37 weeks</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female presents with 35 weeks and 3 days of gestation, AFI = 5 and there is no end-diastolic blood flow. What is the management?&nbsp;</span>(INICET MAY 2018)</p>",
      "unique_key": "Q4566498",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682106,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Immediate termination</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The scenario described indicates fetal compromise, specifically with the findings of oligohydramnios (AFI = 5) and absent end-diastolic flow in the umbilical artery Doppler. These are signs of severe placental insufficiency and fetal distress.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Absent or Reversed End-Diastolic Flow:</strong> This is a critical finding on Doppler ultrasound indicating severe fetal compromise. The absence of end-diastolic flow in the umbilical artery suggests that the fetus is not receiving adequate blood flow, leading to an increased risk of hypoxia and stillbirth.</span></li><li><span style=\"font-size:12pt;\"><strong>Management:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Immediate Termination:</strong> For pregnancies beyond 34 weeks, immediate delivery is indicated to prevent further fetal compromise. This is because the risks of continuing the pregnancy outweigh the benefits, given the significant risk of fetal hypoxia and potential demise.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Give surfactant and wait till 36 weeks:</strong> This is not appropriate because the immediate risk to the fetus requires prompt delivery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Do Doppler everyday to check for reversion:</strong> Continuous monitoring is insufficient in this scenario as the condition indicates severe fetal distress requiring urgent intervention.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Terminate after 37 weeks:</strong> Waiting until 37 weeks is not appropriate due to the immediate risk of fetal compromise.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In cases of severe fetal compromise indicated by absent or reversed end-diastolic flow in the umbilical artery Doppler, especially beyond 34 weeks of gestation, immediate termination of the pregnancy is warranted to prevent fetal hypoxia and potential stillbirth.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 2141, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23202,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9818,
      "choices": [
        {
          "id": 39239,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Promoter insertion</span></span></span></p>"
        },
        {
          "id": 39240,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Enhancer deletion</span></span></span></p>"
        },
        {
          "id": 39241,
          "text": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gene amplification</span></span></span></p>"
        },
        {
          "id": 39242,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Point mutation</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The mutations/changes that convert proto-oncogene to oncogene include all except: (AIIMS NOV 2019)</span></span></p>",
      "unique_key": "Q3513678",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682117,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Enhancer deletion</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Enhancer deletion does not convert a proto-oncogene to an oncogene. </span><span style=\"font-size:12.0pt\">On the contrary, deletion of an enhancer would likely reduce the expression of the gene, potentially reducing its oncogenic potential, rather than increasing it.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Selected oncogenes, Their Mode of Activation, and Associated Human Tumors</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/screenshot-2024-09-06-104500_7dqf6dT.png\" style=\"height:961px; width:1000px\" /></p>\r\n\r\n<p style=\"margin-right:3px\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-180427.png\" style=\"height:287px; width:1000px\" /></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A. Promoter insertion</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Can convert a proto-oncogene to an oncogene by increasing gene transcription.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C. Gene amplification</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Leads to an increased number of gene copies, enhancing gene product levels, and contributing to oncogenesis.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D. Point mutation</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: A common mechanism for converting proto-oncogenes to oncogenes by altering the protein product to make it constitutively active.</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Transformation of proto-oncogene (i.e., normal cell proliferation gene) to oncogenes (i.e., cancer cell proliferation gene) may occur by three mechanisms:</span></span></span></p>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:lower-roman\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Point mutations</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> i.e., an alteration of a single base in the DNA chain. Eg:- RAS oncogene carried in many human tumors such as bladder cancer, pancreatic adenocarcinoma, cholangiocarcinoma. Point mutations, deletions, or insertions in the promoter region of a proto-oncogene that led to increased transcription.&nbsp; </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chromosomal translocations</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> i.e., transfer of a portion of one chromosome carrying protooncogene to another chromosome and making it independent of growth controls.&nbsp; Eg :- Philadelphia chromosome seen in 95% cases of chronic myelogenous leukemia in which c-ABL protooncogene on chromosome 9 is translocated to chromosome 22.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gene amplification</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> i.e., increasing the number of copies of DNA sequence in protooncogene leading to increased mDNA and thus increased or overexpressed gene product. Eg:- Neuroblastoma having n-MYC HSR region,&nbsp; ERB-B1 in breast and ovarian cancer. </span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"margin-right:3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins and Cotran Pathologic basis of disease, 8<sup>th</sup> edition, Pg no. 549-551</span></strong></span></span></p>",
      "correct_choice_id": 39240,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6223,
      "choices": [
        {
          "id": 24861,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">48 hours</span></p>"
        },
        {
          "id": 24862,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">7 days</span></p>"
        },
        {
          "id": 24863,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">30 days</span></p>"
        },
        {
          "id": 24864,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">90 days</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What is the maximum period of voluntary self-admission under the Mental Healthcare Act 2017?(NEET PG 2020)</span></p>",
      "unique_key": "Q7217183",
      "question_audio": null,
      "question_video": null,
      "map_id": 32705201,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 30 days</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Under the Mental Healthcare Act 2017 of India, a person with a mental illness can voluntarily admit themselves to a mental health establishment. The maximum duration for such voluntary admission is up to 30 days. If extended care is needed beyond this period, a fresh admission process is required.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 48 hours:</strong> Not the specified duration for voluntary self-admission.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. 7 days: </strong>Not the maximum duration for voluntary self-admission.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. 90 days:</strong> Far exceeds the duration mentioned in the act for voluntary self-admission.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Under the Mental Healthcare Act 2017 in India, a person with a mental illness can voluntarily admit themselves to a mental health establishment for a <strong>maximum period of 30 days.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Forensic Psychiatry in India, Interface of Indian laws and mental health, 27-28.</strong></span></p>",
      "correct_choice_id": 24863,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20844,
      "choices": [
        {
          "id": 83340,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Vitamin B1</span></p>"
        },
        {
          "id": 83341,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Vitamin B2</span></p>"
        },
        {
          "id": 83342,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Vitamin B6</span></p>"
        },
        {
          "id": 83343,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin C</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient with a history of chronic alcohol use has developed confusion, ataxia, and ophthalmoplegia. Which vitamin deficiency is responsible for this presentation?&nbsp;(NEET PG 2023)</span></p>",
      "unique_key": "Q2951265",
      "question_audio": null,
      "question_video": null,
      "map_id": 32705193,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Vitamin B1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's presentation of confusion, ataxia, and ophthalmoplegia, along with a history of chronic alcohol use, is indicative of a <strong>deficiency in Vitamin B1 (thiamine)</strong>. This clinical picture is consistent with <strong>Wernicke's Encephalopathy</strong>, a serious neurological disorder most commonly seen in individuals with chronic alcohol use. Alcohol use can lead to poor dietary intake and absorption, contributing to thiamine deficiency. Wernicke's Encephalopathy is characterized by the triad of mental confusion, ataxia, and ophthalmoplegia (eye movement abnormalities).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Vitamin B2 (Riboflavin):&nbsp;</strong>Deficiency in Vitamin B2 can lead to symptoms like skin disorders, anemia, and sore throat, but it is not typically associated with the neurological symptoms described in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Vitamin B6 (Pyridoxine):&nbsp;</strong>While Vitamin B6 deficiency can cause neurological symptoms, they are typically peripheral neuropathies or seizures, not the classic triad seen in Wernicke's Encephalopathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Vitamin C:&nbsp;</strong>Deficiency in Vitamin C leads to scurvy, characterized by symptoms like bleeding gums, bruising, joint pain, and poor wound healing, which are not consistent with the patient's presentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In patients with chronic alcohol use presenting with confusion, ataxia, and ophthalmoplegia, a Vitamin B1 (thiamine) deficiency leading to Wernicke's Encephalopathy should be considered.</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Reference: Kaplan &amp; Sadock’s Synopsis of Psychiatry, 12th edition, Page No 277.</strong></span></p>",
      "correct_choice_id": 83340,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14835,
      "choices": [
        {
          "id": 59301,
          "text": "<p><span style=\"font-size:12.0pt;\">Metallosis</span></p>"
        },
        {
          "id": 59302,
          "text": "<p><span style=\"font-size:12.0pt;\">Melanoma</span></p>"
        },
        {
          "id": 59303,
          "text": "<p><span style=\"font-size:12.0pt;\">Ochronosis</span></p>"
        },
        {
          "id": 59304,
          "text": "<p><span style=\"font-size:12.0pt;\">Rosai Dorfmann syndrome</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 60-year-old female underwent hip replacement. After 1 year, she developed fever and pain in the joint. Radiograph revealed loosening of prosthesis. The implant had to be removed. The histological image of the tissue adjoining the implant is shown below. What is the diagnosis?(AIIMS MAY 2020)</span></p><p style=\"margin-left:-4px;text-align:justify;\">&nbsp;</p><p style=\"margin-left:-4px;text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/18/whatsapp-image-2023-06-12-at-190121011010201026_page_68_page_101.jpg\" alt=\"\" width=\"400\" height=\"149\"></p>",
      "unique_key": "Q4074771",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682126,
      "difficulty_level": "intermediate",
      "subjects_id": [
        15
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Metallosis</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The microscopic image shows multiple foci of extracellular metal deposits (seen as black deposits) surrounded by inflammatory cells, suggestive of metallosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>METALLOSIS</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Metallosis is a rare, potentially fatal complication after arthroplasty characterized by the deposition and build-up of metal debris in the soft tissues of the body, associated with <strong>metal-on-metal prosthetic devices</strong>, but it has also been described in non-metallic prostheses.</span></li><li><span style=\"font-size:12.0pt;\">It is defined as <strong>aseptic fibrosis, local necrosis, or loosening of a device secondary to metal corrosion </strong>and release of wear debris.</span></li><li><span style=\"font-size:12.0pt;\">It occurs due to metallic erosion and release of metallic debris products, which induce massive local cytokines liberation from inflammatory cells.</span></li><li><span style=\"font-size:12.0pt;\">It can present with local/systemic symptoms and signs due to a chronic inflammatory host response.</span></li><li><span style=\"font-size:12.0pt;\">The local effects have been described as pseudotumours or osteolysis.</span></li><li><span style=\"font-size:12.0pt;\">The systemic effects are caused by an immunological response to metal debris, including constitutional symptoms such as nausea, vomiting and malaise, cognitive impairment, haematological abnormalities and neuromuscular changes.</span></li><li><span style=\"font-size:12.0pt;\">Risk factor for the development of metallosis include female gender, bilateral implants, high doses of corticosteroids, renal insufficiency and a suppressed immune system.</span></li><li><span style=\"font-size:12.0pt;\">Its <strong>histology is characterized by widespread lymphoplasmacytic and histiocytic infiltration</strong> around metal debris, foreign body giant cells, metal particles, extracellular metal deposits and intracytoplasmic debris in giant cells.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Treatment consists of surgical revision</strong> with replacement of the prosthesis components, complete surgical debridement of osteolytic lesions and bone grafting with allograft chips.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Complete removal of all metal debris is difficult</strong> and may result in extensive tissue damage.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Melanoma</strong>. <strong>Melanoma</strong>, also known as&nbsp;<strong>malignant melanoma</strong>, is a type of&nbsp;cancer that develops from the&nbsp;pigment-producing cells known as&nbsp;<strong>melanocytes</strong>. Melanomas typically occur in the skin.&nbsp;In women, they most commonly occur on the legs, while in men, they most commonly occur on the back.&nbsp;About 25% of melanomas develop from&nbsp;moles. Changes in a mole that can indicate melanoma include an increase in size, irregular edges, change in color, itchiness, or&nbsp;skin breakdown. The primary cause of melanoma is&nbsp;ultraviolet light&nbsp;(UV) exposure in those with low levels of the&nbsp;skin pigment&nbsp;melanin.&nbsp;Those with many moles, a history of affected family members, and&nbsp;poor immune function&nbsp;are at greater risk.&nbsp;Diagnosis is by&nbsp;biopsy. Using&nbsp;sunscreen&nbsp;and avoiding UV light may prevent melanoma.&nbsp;Treatment is typically removal of the melanoma and potentially affected tissue (border around the melanoma) by surgery. In those with slightly larger cancers, nearby&nbsp;lymph nodes&nbsp;may be tested for metastasis.&nbsp;For those in whom melanoma has spread,&nbsp;immunotherapy,&nbsp;biologic therapy,&nbsp;radiation therapy, or&nbsp;chemotherapy&nbsp;may improve survival.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Ochronosis</strong>. Ochronosis is named for the reddish-brown hue of tissue termed \"ochre-like\". It is inborn error of metabolism. Ochronosis is due to deposition of a phenolic compound – \"alkaptons\" polymerizing into connective tissue, leading to black urine disease called <strong>alkaptonuria</strong>. Inherited in an autosomal recessive fashion, alkaptonuria is an inactive gene, mapped on chromosome 3q21-23 coding for the enzyme homogentisate 1,2 dioxygenase (HGD). The result is systemic sequestration of homogentisate, that upon the decay to benzoquinone, can irreversibly bind with collagen. Polymerization of this molecule takes on an iridescent dark hue, tinting affected tissue and turning urine black. Aside from just discoloration, these processes can cause degradation, degeneration, and developmental problems in all types of collagen. The earliest sign is from parents who notice infants’ diapers are&nbsp;black in color. This disease can be insidious and manifest later in life. Patients may&nbsp;present with back pain or large joint arthralgias in their post-teenage years or early 30s. Pigmentation of the sclera and pinna of the ear is often seen later in life. Constant tendon ruptures especially with minimal trauma. On physical examination, thickened Achilles tendon and bursa effusions are common. For alkaptonuria, a chromatography assay in the urine for homogentisate can be diagnostic, especially, if the color change is noted after being exposed to the air.</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">A genetic test can determine the existence of the autosomal recessive disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Rosai-Dorfman syndrome.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Rosai-Dorfman disease is a disease that occurs when the body produces too many histiocytes in the lymph nodes. These histiocytes accumulate in the cervical nodes most commonly. Histiocytes may also build up in the skin, upper respiratory tract, and sinuses. Rosai-Dorfman disease is seldom life-threatening. In many instances, the patient’s symptoms resolve on their own. The majority of patients experience enlarged lymph nodes on both sides of the neck. While often painless, these nodes can swell and grow rather larger. Swelling may also be reported in the lymph nodes of the groin, armpits, and in the central portion of the chest. This swelling may be accompanied by fever. The diagnosis is made following a tissue biopsy from the affected site. Though it is most commonly diagnosed in the first 10 years of life, it is also found in adults, affecting men and women equally.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The image in the question shows extracellular metal deposits (black deposits) surrounded by inflammatory cells, suggestive of metallosis.</span></li><li><span style=\"font-size:12.0pt;\">It is associated with metal-on-metal prosthetic devices.</span></li></ul>",
      "correct_choice_id": 59301,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13716,
      "choices": [
        {
          "id": 54825,
          "text": "<p><span style=\"font-size:12.0pt;\">Allis test</span></p>"
        },
        {
          "id": 54826,
          "text": "<p><span style=\"font-size:12.0pt;\">Thomas test</span></p>"
        },
        {
          "id": 54827,
          "text": "<p><span style=\"font-size:12.0pt;\">Ober test</span></p>"
        },
        {
          "id": 54828,
          "text": "<p><span style=\"font-size:12.0pt;\">Trendelenburg test</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 55-year-old female came with hip flexor contracture. What is the most likely test to be done in this case?(AIIMS MAY 2018)</span></p>",
      "unique_key": "Q1060947",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682104,
      "difficulty_level": "beginner",
      "subjects_id": [
        15
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Thomas test</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>THOMAS TEST</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">It is used to assess for hip flexion contracture and psoas syndrome.</span></li><li><span style=\"font-size:12.0pt;\">It is especially useful when the fixed flexion deformity is masked by excessive lordosis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Steps:</strong></span></li></ul><p>&nbsp;</p><p><span style=\"color:#231f20;font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/17/whatsapp-image-2023-06-12-at-190121011010201026_page_68_page_87.jpg\" alt=\"\" width=\"700\" height=\"658\"></strong></span></p><p>&nbsp;</p><p><span style=\"color:#231f20;font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/31/picture1.jpg\" alt=\"\" width=\"300\" height=\"222\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Allis test.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">The Galeazzi test, also called&nbsp;Allis test, is used to assess hip dislocation, specifically testing for developmental dysplasia of the hip (DDH) and can also be used to assess significant leg length inequality. The examination is performed with the child lying supine and their hips flexed to 45 degrees with knees flexed to 90 degrees, and feet on examining table. In this position, look for symmetry in the level of the knees. Galeazzi’s test is positive if the height of the knees is asymmetrical, and may be due to hip dislocation, DDH, congenital femoral shortening, fracture, other congenital conditions. It is also helpful in determining whether the leg length inequality is primarily from the femur or the tibia and can be used to assess leg length with knee or hip flexion contracture.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/31/picture2.jpg\" alt=\"\" width=\"400\" height=\"184\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Ober test</strong>. The Ober's test evaluates a tight, contracted or inflamed Tensor Fasciae Latae (TFL) and Iliotibial band (ITB). The patient should be in side-lying with the affected side up. Bottom knee and hip should be flexed to flatten the lumbar curve. Stand behind the patient and firmly stabilize the pelvis/greater trochanter to prevent movement in any direction. Grasp the distal end of the patient’s affected leg with your other hand and flex the leg to a right angle at the knee. Extend and abduct the hip joint. Slowly lower the leg towards the table, adduct hip until motion is restricted. Ensure that the hip does not internally rotate and flex during the test and the pelvis must be stabilized. As allowing the thigh to drop in flexion and internal rotation would 'give in' to the tight TFL and not accurately test the length. If the ITB is normal, the leg will adduct with the thigh dropping down slightly below the horizontal, the test is called negative. If the ITB is tight, the leg would remain in the abducted position and the patient would experience lateral knee pain, the test is called positive.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/31/picture3.jpg\" alt=\"\" width=\"400\" height=\"212\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Trendelenburg test.&nbsp;</strong>The aim of&nbsp;<strong>Trendelenburg’s</strong>&nbsp;<strong>test</strong>&nbsp;is to assess the strength of the hip abductors, specifically the gluteus medius and minimus. It is done when a patient complains of a&nbsp;<strong>limp</strong>, or&nbsp;<strong>hip pain</strong>&nbsp;or as part of a normal physical examination assessing&nbsp;<strong>gait</strong>. If the patient is comfortable to stand alone, stand behind the patient. Alternatively, stand in front of the patient, with their forearms positioned on yours to support them. Ask the patient to lift each foot in turn off the ground. When the patient lifts their&nbsp;<strong>right</strong>&nbsp;foot, the&nbsp;<strong>left</strong>&nbsp;hip abductors are being tested. When the patient lifts their&nbsp;<strong>left</strong>&nbsp;foot, the&nbsp;<strong>right</strong>&nbsp;hip abductors are being tested. Position your hands on the patient’s&nbsp;<strong>iliac crests</strong>. Observe carefully if the hip on the unsupported side&nbsp;<strong>lifts</strong>&nbsp;or&nbsp;<strong>droops</strong>. If the patient is using your arms for support, you will feel them pressing down on one of your arms if their hip abductors are unable to support their weight. A positive Trendelenburg’s sign (pathological) involves&nbsp;<strong>sagging</strong>&nbsp;of the pelvis on the&nbsp;<strong>unsupported side</strong>&nbsp;due to the abductor muscles failing to stabilise the hip towards the weight-bearing femur.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/31/picture4.jpg\" alt=\"\" width=\"300\" height=\"332\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Thomas test is used to assess the hip flexor contracture.</span></li></ul>",
      "correct_choice_id": 54826,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5676,
      "choices": [
        {
          "id": 22676,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">10% buffered formalin</span></span></span></p>"
        },
        {
          "id": 22677,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">95% ethyl alcohol</span></span></span></p>"
        },
        {
          "id": 22678,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Air dried</span></span></span></p>"
        },
        {
          "id": 22679,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">None of the above</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fixative for PAP smear:&nbsp;(INICET MAY 2017)</span></span></p>",
      "unique_key": "Q4878922",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682155,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) 95% ethyl alcohol</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most commonly used fixative for a Pap smear is 95% ethyl alcohol. This fixative preserves the cellular detail necessary for accurate cytological evaluation by preventing cellular autolysis and degradation. The use of 95% ethyl alcohol ensures that the cells maintain their morphology, which is critical for detecting abnormalities such as dysplasia or carcinoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">95% Ethyl Alcohol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is the standard fixative for Pap smears, ensuring optimal preservation of cellular details.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ethanol Spray:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> In modern practice, an ethanol spray fixative is available, which can be conveniently used in an office setting to fix the smear immediately after it is taken.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. 10% buffered formalin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This fixative is typically used for histological specimens rather than cytological smears like the Pap test.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Air dried:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Air drying is not recommended for Pap smears as it can cause cellular distortion and artifacts, which complicate the interpretation of the smear.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. None of the above:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is incorrect as 95% ethyl alcohol is the correct fixative.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most commonly used fixative for a Pap smear is 95% ethyl alcohol, which preserves cellular morphology necessary for accurate cytological evaluation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 271, DC Dutta&rsquo;s Textbook of Gynecology 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 22677,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14429,
      "choices": [
        {
          "id": 57677,
          "text": "<p><span style=\"font-size:12.0pt;\">Veress needle</span></p>"
        },
        {
          "id": 57678,
          "text": "<p><span style=\"font-size:12.0pt;\">Morris' needle</span></p>"
        },
        {
          "id": 57679,
          "text": "<p><span style=\"font-size:12.0pt;\">Yankauer suction tip</span></p>"
        },
        {
          "id": 57680,
          "text": "<p><span style=\"font-size:12.0pt;\">Von Graefe needle</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the instrument shown below used in laparoscopic surgeries?</span> <span style=\"font-size:12.0pt;\">(AIIMS NOV 2019)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/06/untitled-660.jpg\" alt=\"\" width=\"334\" height=\"191\"></span></p>",
      "unique_key": "Q6255790",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682105,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Veress needle</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The instrument in the image is Veress Needle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Veress needle is a surgical instrument used to create pneumoperitoneum in laparoscopic surgeries. It consists of a long, slender needle with a sharp, pointed tip and a hollow center. The needle is attached to a handle and a valve that controls the flow of gas into the abdominal cavity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Veress needle is inserted into the abdominal cavity through a small incision, usually in the umbilicus (closed technique). The surgeon first lifts the abdominal wall away from the underlying organs and tissues, then inserts the Veress needle at a 45-degree angle to the skin and advances it until it reaches the abdominal cavity. The valve is then opened to allow gas (usually carbon dioxide) to flow into the abdominal cavity, creating a space for the laparoscope and other instruments.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Morris' needle</strong>: This is not commonly used for pneumoperitoneum or laparoscopic access.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Yankauer suction tip</strong>: This is a suction instrument used to clear surgical sites of blood and fluids, not for gas insufflation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Von Graefe needle</strong>: Primarily used in ophthalmic procedures, unrelated to laparoscopic surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The use of the Veress needle helps to minimize the risk of injury to surrounding organs and tissues during laparoscopic procedures. It is typically used at the beginning of the procedure, after which the laparoscope and other instruments are inserted through separate ports or trocars placed in the abdomen. The Veress needle is then removed and the incision closed.</span></p>",
      "correct_choice_id": 57677,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ImageBased",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31817,
      "choices": [
        {
          "id": 127138,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A</span></span></p>"
        },
        {
          "id": 127139,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">B</span></span></p>"
        },
        {
          "id": 127140,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">C</span></span></p>"
        },
        {
          "id": 127141,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">D</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the figure shown below, mechanism of action of valproate is best represented by:</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/30/1.jpg\" style=\"height:302px; width:400px\" /></span></span></p>",
      "unique_key": "Q7047263",
      "question_audio": null,
      "question_video": null,
      "map_id": 32705484,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) A</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Mechanisms of Action of Sodium Valproate</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Enhancement of GABA Activity:</strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:disc\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Valproate increases the levels of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the brain. This is achieved primarily by stimulating the enzyme glutamic acid decarboxylase that helps in formation of GABA from glutamic acid. Valproate also acts by inhibiting GABA transaminase, the enzyme responsible for GABA breakdown, leading to increased GABA availability.</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Inhibition of Voltage-Gated Sodium Channels:</strong></span></span>\r\n\t<ul style=\"list-style-type:disc\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Valproate modulates voltage-gated sodium channels in the neurons. By prolonging the recovery of these channels from inactivation, valproate reduces the high-frequency repetitive firing of action potentials.</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Inhibition of T-Type Calcium Channels:</strong></span></span>\r\n\t<ul style=\"list-style-type:disc\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Valproate also affects T-type calcium channels, particularly in thalamic neurons. By inhibiting these channels, it reduces the rhythmic cortical discharges that are often seen in absence seizures.</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong> B represents the mechanism of action of drugs like gabapentin and pregabalin. These act by increasing the release of GABA.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong> C represents the mechanism of action of tiagabine. It acts by inhibiting the reuptake of GABA.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong> D is site of action of benzodiazepines like diazepam and lorazepam.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Valproate increases GABA levels by stimulating the enzyme GAD (glutamic acid decarboxylase) to convert glutamate into GABA and by inhibiting GABA transaminase, preventing the breakdown of GABA.</span></span></p>",
      "correct_choice_id": 127138,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 63624,
      "choices": [
        {
          "id": 253701,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3 and 5&nbsp;</span></p>"
        },
        {
          "id": 253702,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3 and 4&nbsp;</span></p>"
        },
        {
          "id": 253703,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2 and 3</span></p>"
        },
        {
          "id": 253704,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3 and 5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">For the detection of Diabetes Mellitus in a population over 40 but less than 60, two screening tests are performed simultaneously, without considering the result of one before conducting the other. This method leads to:</span></p><p><br><span style=\"font-size:16px;\">1. Decreased Specificity for detecting DM</span><br><span style=\"font-size:16px;\">2. Increased Sensitivity for detecting DM</span><br><span style=\"font-size:16px;\">3. Increased Negative Predictive Value</span><br><span style=\"font-size:16px;\">4. Increased Specificity for detecting DM</span><br><span style=\"font-size:16px;\">5. Reduced sensitivity for detecting diabetes</span></p>",
      "unique_key": "Q1595166",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682127,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C)&nbsp;1, 2 and 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">When two screening tests are used in&nbsp;<strong>parallel</strong>, both tests are performed independently, and the results of one test do not influence whether the second test is done. The primary purpose of using tests in parallel is to increase the likelihood of detecting a condition if it is present, which affects sensitivity and predictive values as follows:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>1. Increased Sensitivity for detecting DM (B)</strong>: Performing tests in parallel increases the overall sensitivity, meaning that more cases of diabetes mellitus are likely to be detected. This is because if either test returns positive, the condition is considered present, reducing the chance of a false negative.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>2. Decreased Specificity for detecting DM (A)</strong>: While sensitivity increases, specificity decreases. This occurs because a higher likelihood of obtaining a positive result also means there is an increased chance of false positives, thereby reducing specificity.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>3. Increased Negative Predictive Value (C)</strong>: Negative Predictive Value (NPV) improves because if both tests come back negative, there is a very high probability that the person does not have diabetes mellitus. Thus, the reliability of a negative result is strengthened.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>4. Increased Specificity for detecting DM:&nbsp;</strong>Incorrect, Using tests in parallel reduces specificity because the probability of a false positive increases when either test is sufficient for a positive result.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>5. Decreased Sensitivity for detecting DM:&nbsp;</strong>Incorrect, The sensitivity actually increases when tests are used in parallel, as the likelihood of detecting true positive cases is higher.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Performing two screening tests in parallel increases sensitivity and negative predictive value while decreasing specificity.</span></p>",
      "correct_choice_id": 253703,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60831,
      "choices": [
        {
          "id": 242617,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NYHA 3</span></span></span></p>"
        },
        {
          "id": 242618,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NYHA 4</span></span></span></p>"
        },
        {
          "id": 242619,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MMRC 4</span></span></span></p>"
        },
        {
          "id": 242620,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MMRC 5</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with heart disease has breathlessness on going to the bathroom. What grade does he belong to? (INICET NOV 2022)</span></span></p>",
      "unique_key": "Q1807462",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682118,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) NYHA 3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This patient with heart disease experiences dyspnea while performing an </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">activity of daily living</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (going to the bathroom), which classifies him as </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NYHA Class 3</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">New York Heart Association (NYHA)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> classification system is used to classify patients with heart disease based on their </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">functional disability</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NYHA Class I</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: No limitation of physical activity; ordinary activity does not cause symptoms.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NYHA Class II</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Slight limitation of physical activity; comfortable at rest, but ordinary activity causes symptoms.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NYHA Class III</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Marked limitation of physical activity; comfortable at rest, but </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">less than ordinary activity</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (e.g., walking to the bathroom) causes symptoms.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NYHA Class IV</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Unable to carry out any physical activity without symptoms, or symptoms at rest.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In this case, the patient&#39;s breathlessness when going to the bathroom indicates a significant limitation, making him fall under </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Class III</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. NYHA 4: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Class 4 indicates severe limitations, where the patient is unable to perform any activity without symptoms or experiences symptoms even at rest, which is more severe than this patient&rsquo;s current condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. MMRC 4 and D. MMRC 5: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Modified Medical Research Council (MMRC) Dyspnea Scale</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is used to assess dyspnea in </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">chronic obstructive pulmonary disease (COPD)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. This classification scale does not apply to patients with heart disease. The MMRC scale is used to assess the degree of breathlessness in COPD, ranging from 0 to 4, where higher numbers indicate more severe breathlessness.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NYHA classification</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is commonly used to evaluate patients with </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">heart failure</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> based on their level of physical activity and symptom severity. Class III patients experience significant limitations in activity, where even mild exertion (such as going to the bathroom) causes symptoms like breathlessness.</span></span></span></p>",
      "correct_choice_id": 242617,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2573,
      "choices": [
        {
          "id": 10277,
          "text": "<p><span style=\"font-size:12.0pt;\">Protein</span></p>"
        },
        {
          "id": 10278,
          "text": "<p><span style=\"font-size:12.0pt;\">Fat</span></p>"
        },
        {
          "id": 10279,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbohydrates</span></p>"
        },
        {
          "id": 10280,
          "text": "<p><span style=\"font-size:12.0pt;\">Mixed meal having all 3 in equal amount</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The maximum thermic effect is seen with a meal which has? (</span>INICET Nov 2020)</p>",
      "unique_key": "Q7274978",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682119,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Protein</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Increased heat production or increased metabolic rate following the intake of food is called as thermogenic effect of food or diet-induced thermogenesis</strong> or <strong>specific dynamic action (SDA) of food.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Part of this is due to the expenditure of energy for digestion; absorption and active transport of products of the digestion. Another reason for this expenditure of energy is that reserve materials, such as glycogen, triacyl glycerol, protein, etc. are synthesized from small molecules available after digestion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>A high protein diet leads to higher protein turnover resulting in increased diet induced thermogenesis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">T<strong>he values of SDA are: for proteins 30%, for lipids 15%, and for carbohydrates 5%</strong>. This means that <strong>out of every 100 grams of proteins consumed, the energy available for doing useful work is 30% less than the calculated value.</strong></span></p><p><span style=\"font-size:12.0pt;\">It is a common experience that during hot weather following the consumption of a protein rich meal, one feels hot and humid for a while. On the other hand, in cold weather, the same would provide a comfortable feeling</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;</strong></span><span style=\"font-size:12pt;\"><strong>B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Fat:&nbsp;</strong>Fats have a moderate thermic effect, lower than proteins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;</strong></span><span style=\"font-size:12pt;\"><strong>C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Carbohydrates:&nbsp;</strong>Carbohydrates have the lowest thermic effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;</strong></span><span style=\"font-size:12pt;\"><strong>D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Mixed meal having all 3 in equal amount:&nbsp;</strong>A mixed meal would have a combined thermic effect that is a weighted average of the individual macronutrient effects, which would be lower than that of a protein-only meal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Real-world Observation:&nbsp;</strong>It is commonly observed that after consuming a protein-rich meal, especially during hot weather, individuals may feel hot and humid due to the increased heat production. Conversely, in cold weather, the same meal can provide a warming effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The maximum thermic effect is seen with protein-rich meals, as proteins require more energy for digestion, absorption, and metabolism compared to fats and carbohydrates.</span></p>",
      "correct_choice_id": 10277,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13799,
      "choices": [
        {
          "id": 55157,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿a-12, b-9, c-4, d-1</span></p>"
        },
        {
          "id": 55158,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿a-1, b-4, c-12, d-9</span></p>"
        },
        {
          "id": 55159,
          "text": "<p><span style=\"font-size:12.0pt;\">a-1, b-4, c-9, d-12</span></p>"
        },
        {
          "id": 55160,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿a-12, b-4, c-9, d-1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In the given section of the heart, match the marked (4, 9, 12, 1) structures:</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/picture7.jpg\" alt=\"\" width=\"300\" height=\"244\"></p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12pt;\">Outflow to pulmonary trunk (blue)</span></li><li><span style=\"font-size:12pt;\">Mitral valve</span></li><li><span style=\"font-size:12pt;\">Tricuspid valve</span></li><li><span style=\"font-size:12pt;\">Papillary muscles</span></li></ol>",
      "unique_key": "Q5264245",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682157,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. a-1, b-4, c-9, D-12</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The image shows a cut and reflected section of the heart.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The ventricles can be identified based upon the wall thickness - Left ventricle has thicker walls.</span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12pt;\">Outflow to pulmonary trunk (marked as 1): This structure represents the exit point for blood traveling to the lungs for oxygenation.</span></li><li><span style=\"font-size:12pt;\">Mitral valve (marked as 4): Located between the left atrium and the left ventricle, the mitral valve regulates blood flow within the heart.</span></li><li><span style=\"font-size:12pt;\">Tricuspid valve (marked as 9): This valve, situated between the right atrium and right ventricle, prevents backflow of blood from the ventricles to the atria.</span></li><li><span style=\"font-size:12pt;\">Papillary muscles (marked as 12): These muscles are attached to the ventricular walls and play a critical role in the function of the mitral and tricuspid valves via tendon-like chords.</span></li></ol><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The correct match is:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">1. Outflow to pulmonary trunk (blue)</span></p><p><span style=\"font-size:12pt;\">2. Left atrium</span></p><p><span style=\"font-size:12pt;\">3. Pulmonary veins (light red)</span></p><p><span style=\"font-size:12pt;\">4. Mitral valve</span></p><p><span style=\"font-size:12pt;\">5. Aorta (red).</span></p><p><span style=\"font-size:12pt;\">6. Superior vena cava (blue)</span></p><p><span style=\"font-size:12pt;\">7. Aortic semi lunar valve</span></p><p><span style=\"font-size:12pt;\">8. Right atrium</span></p><p><span style=\"font-size:12pt;\">9. Tricuspid valve</span></p><p><span style=\"font-size:12pt;\">10. Right ventricle</span></p><p><span style=\"font-size:12pt;\">11. Inferior vena cave (blue)</span></p><p><span style=\"font-size:12pt;\">12. Papillary muscles</span></p><p><span style=\"font-size:12pt;\">13. Left ventricle</span></p>",
      "correct_choice_id": 55159,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6233,
      "choices": [
        {
          "id": 24901,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage 1</span></p>"
        },
        {
          "id": 24902,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage 2</span></p>"
        },
        {
          "id": 24903,
          "text": "<p><span style=\"font-size:12.0pt;\">Stage 3</span></p>"
        },
        {
          "id": 24904,
          "text": "<p><span style=\"font-size:12.0pt;\">REM sleep</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the stage of sleep based on the following EEG finding?&nbsp;(NEET PG 2020)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/12/untitled-359.jpg\" alt=\"\" width=\"300\" height=\"213\"></p>",
      "unique_key": "Q1793209",
      "question_audio": null,
      "question_video": null,
      "map_id": 32705200,
      "difficulty_level": "intermediate",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) REM sleep</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">EEG recording is showing \"<strong>Sawtooth waves</strong>\" which are characteristic of REM (Rapid Eye Movement) sleep. REM sleep is also associated with rapid eye movements, muscle atonia (paralysis), and dreaming.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Stage 1:</strong> Transition between wakefulness and sleep, contains <strong>theta waves</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Stage 2:</strong> Characterized by <strong>sleep spindles</strong> and <strong>K-complexes</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Stage 3:</strong> Deep sleep or slow-wave sleep, characterized by <strong>delta waves</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Rapid Eye Movement (REM) sleep follows NREM sleep. EEG in REM sleep shows sawtooth waves and increased activity similar to awake state (<strong>beta activity</strong>) along with return of <strong>alpha activity</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Kaplan &amp; Sadock’s Synopsis of Psychiatry, 11th edition, Page No 534.</strong></span></p>",
      "correct_choice_id": 24904,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6646,
      "choices": [
        {
          "id": 26553,
          "text": "<p><span style=\"font-size:18px;\">More common after life threatening trauma</span></p>"
        },
        {
          "id": 26554,
          "text": "<p><span style=\"font-size:18px;\">Seen in seizure and migraine patients</span></p>"
        },
        {
          "id": 26555,
          "text": "<p><span style=\"font-size:18px;\">More common in females</span></p>"
        },
        {
          "id": 26556,
          "text": "<p><span style=\"font-size:18px;\">Mean age at onset is 25 years</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\">Which of the following is true regarding depersonalization disorder? (AIIMS May 2019)</span></p>",
      "unique_key": "Q2776584",
      "question_audio": null,
      "question_video": null,
      "map_id": 32682095,
      "difficulty_level": "difficult",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. B) Seen in seizure and migraine patients</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">This is a controversial question as the interpretation of question can be different but based on the given options, the most appropriate answer will be option B.&nbsp;</span></p><p><br><span style=\"font-size:18px;\">As per CTP 11th Edition – Depersonalization is seen in a variety of neurologic and psychiatric disorders and is common in complex partial seizures</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Depersonalization disorder (DPD) is characterized by persistent or recurrent feelings of detachment or estrangement from one's own thoughts, emotions, body, or surroundings.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">DPD can be associated with other medical conditions, including seizure disorders and migraines, as stated in option B.</span><br>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A</strong>. While it can occur as a reaction to life-threatening trauma, it is not specifically more common after such events.&nbsp;</span></p><p><br><span style=\"font-size:18px;\">As per CTP 11th Edition – Many individuals with depersonalization/derealization disorder do not identify an immediate traumatic antecedent and do not report a clear precipitant to disorder onset. On the other hand, nontraumatic stressors—such as severe interpersonal, financial, or occupational losses—have been associated with the onset or exacerbation of the disorder.</span><br>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. </strong>The disorder has a slight male predominance.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. </strong>The mean age of onset for depersonalization disorder is typically in the mid to late teens, not 25 years.</span><br>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Depersonalisation disorder is characterized by feelings of unreality or detachment from oneself or one’s body. The patients feel ‘as if’ they have changed. They can be associated with medical conditions such as migraine, seizure disorder, cerebral tumors and encephalitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Reference: A Short Textbook of Psychiatry, 7th edition, Page No 110</strong></span></p>",
      "correct_choice_id": 26554,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Controversial",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6234,
      "choices": [
        {
          "id": 24905,
          "text": "<p><span style=\"font-size:12.0pt;\">Major depressive disorder with psychotic features</span></p>"
        },
        {
          "id": 24906,
          "text": "<p><span style=\"font-size:12.0pt;\">Schizophrenia</span></p>"
        },
        {
          "id": 24907,
          "text": "<p><span style=\"font-size:12.0pt;\">Schizoaffective disorder</span></p>"
        },
        {
          "id": 24908,
          "text": "<p><span style=\"font-size:12.0pt;\">Delusional disorder</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A middle-aged female patient presents with a history of loss of interest in day-to-day activities, weight loss, insomnia, and sadness for six months. She also recalls hearing a voice once that ordered her to kill herself. What is the DSM-V diagnosis?&nbsp;(NEET PG 2020)</span></p>",
      "unique_key": "Q3449600",
      "question_audio": null,
      "question_video": null,
      "map_id": 32705199,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Major depressive disorder with psychotic features</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's symptoms of loss of interest in daily activities, weight loss, insomnia, and persistent sadness align with <strong>major depressive disorder</strong>. The presence of auditory hallucination (voice ordering her to commit suicide) indicates an <strong>additional psychotic feature</strong>. Hence, the diagnosis would be <strong>Major Depressive Disorder with Psychotic Features</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Schizophrenia:</strong> It is a chronic disorder typically lasting more than 6 months, with symptoms like delusions, hallucinations, disorganized speech, etc. without a predominant mood episode.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Schizoaffective disorder:</strong> It has features of both schizophrenia and mood disorders concurrently.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Delusional disorder:</strong> The primary feature is a persistent delusion without other symptoms of psychosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"color:#374151;font-size:12.0pt;\">Psychotic depression </span><span style=\"font-size:12.0pt;\">In Major Depressive Disorder with Psychotic Features (also known as <strong>psychotic depression</strong>), </span><span style=\"color:#374151;font-size:12.0pt;\">is seen in moderate to severe depressive disorder where the individual experiences both depressive symptoms and psychosis, such as delusions or hallucinations. These psychotic symptoms could be <strong>mood congruent </strong>(i.e, content of delusion/ hallucination is consistent with the depressed mood) or mood incongruent. </span><span style=\"font-size:12.0pt;\">Psychotic symptoms align with the mood episode's theme, differentiating it from schizoaffective disorder. Treatment includes typically combining antipsychotics with antidepressants.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Kaplan &amp; Sadock’s Synopsis of Psychiatry, 11th edition, Page No 356, 360.</strong></span></p>",
      "correct_choice_id": 24905,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20842,
      "choices": [
        {
          "id": 83332,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Squeeze Technique</span></p>"
        },
        {
          "id": 83333,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Sensate Focus Technique</span></p>"
        },
        {
          "id": 83334,
          "text": "<p><span style=\"font-size:12.0pt;\">Exposure and Response Prevention</span></p>"
        },
        {
          "id": 83335,
          "text": "<p><span style=\"font-size:12.0pt;\">Cognitive Behavioral Therapy</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A husband and wife presented to the outpatient department with complaints of the husband's premature ejaculation, which is leading to frequent conflicts between them. Which of the following non-pharmacological techniques is most appropriate for treatment? (NEET PG 2023)</span></p>",
      "unique_key": "Q7861916",
      "question_audio": null,
      "question_video": null,
      "map_id": 32705195,
      "difficulty_level": "beginner",
      "subjects_id": [
        16
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Squeeze Technique</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For the management of premature ejaculation, the <strong>Squeeze Technique</strong> is a specific non-pharmacological method that is often recommended. This technique involves sexual stimulation until the individual is close to ejaculation. At that point, the partner squeezes the shaft of the penis (coronal ridge of glans) for several seconds, which can delay ejaculation. This process is repeated several times before ejaculation is allowed to occur. The Squeeze Technique helps in increasing the time before ejaculation and is directly targeted at managing premature ejaculation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Sensate Focus Technique:&nbsp;</strong>While this technique, which involves non-genital pleasuring, can be helpful in reducing performance anxiety and improving sexual communication, it is not specifically designed for the treatment of premature ejaculation. It is useful for erectile dysfunction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Exposure and Response Prevention:&nbsp;</strong>This is a technique used primarily in the treatment of obsessive-compulsive disorder and is not typically employed for premature ejaculation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Cognitive Behavioral Therapy (CBT):&nbsp;</strong>CBT can be useful for addressing underlying psychological issues contributing to sexual dysfunction, but it is a more general approach and not as specifically targeted for premature ejaculation as the Squeeze Technique.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Squeeze Technique is a specific non-pharmacological method effective in the management of premature ejaculation. It involves squeezing the penis before the point of ejaculation to delay it and can be repeated several times to increase the time before ejaculation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Kaplan &amp; Sadock’s Synopsis of Psychiatry, 12th edition, Page 531.</strong></span></p>",
      "correct_choice_id": 83332,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}